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ABSTRACT 
 
SUNGJIN PARK: DEVELOPMENT OF THE ENGINEERED BIOLOGICAL MODEL 
SYSTEMS AND CHEMOSELECTIVE REDOX RESPONSIVE LIGATION (CRRL) 
 
(Under the direction of Dr. Muhammad N. Yousaf) 
 
Biological model substrates were developed and engineered for cell adhesion and 
migration studies. The substrates are based on hydroquinone-presenting (HQ) self-assembled 
monolayers on gold surfaces that can be electrochemically activated for ligand 
immobilization. Combined with tetra(ethylene glycol)-terminated alkanethiol, the substrates 
secure biospecific interactions between cell adhesion receptors and ligands, as well as 
provide the ability to characterize the amount of immobilized ligand. In chapter 2, these 
model surfaces were used to study the biological role of decoupled PHSRN, found in the 9th 
type III domain of fibronectin when it is presented to  Swiss 3T3 albino mouse fibroblasts. 
We found that PHSRN-integrin interactions enhanced lamellipodia protrusions by increasing 
Rac1 activity, which is associated with cross-talk between adhesion receptors and soluble 
factors. These novel biological model systems were further extended toward the development 
of a new platform based on reacting soluble ketone- or aldehyde-tethered ligands to surface-
bound oxyamine-containing alkanethiols to generate a covalent oxime linkage to the surface 
in chapter 3. By photoprotecting the oxyamine group with nitroveratryloxycarbonyl chloride  
and then selectively deprotecting through microfiche film, bioligands and fibroblast cells 
could be immobilized in patterns and gradients. Expanding on the HQ platform in chapters 1 
and 2, a general methodology to immobilize and release oxyamine ligands on an 
 iii 
electroactive quinone monolayer by electrochemical reduction was reported in chapter 4. The 
HQ surface is catalytic, can perform several rounds of immobilization and release of ligands, 
and also converts the oxyamine functional group to a hydroxyl group by a mild 
electrochemical potential. In chapter 5, a general chemoselective redox responsive ligation 
and release strategy for molecular conjugation and cleavage was introduced. The HQ is 
converted to benzoquinone to form stable quinone oxime with oxyamine-tethered ligands 
that can be further cleaved by reduction, yielding aminophenol and hydroxyl-terminated 
ligand. The conjugation and cleavage reactions are controlled by mild chemical or 
electrochemical redox signals and can be performed at physiological conditions (pH 7.4, 37 
oC) without the use of a catalyst. 
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1.1 CELL ADHESION TO EXTRA-CELLULAR MATRIX 
 
 Most mammalian cells bind adhesion molecules to survive, migrate, proliferate, and 
differentiate1-3. The cellular environment is mixture of many kinds of biomolecules that are 
secreted and deposited by various types of cells; collectively named the extracellular matrix 
(ECM). Cell adhesion onto the surface is mediated by cellular receptors such as integrins and 
syndecans engaging cell binding domains of ECM molecules. The interactions between the 
integrins and cell-binding molecules initiate co-localization of integrins, leading to 
recruitment of intracellular proteins at its cytoplasmic domain4. The adhesion structures then 
transmit the adhesion mediated signals into the cells through various kinases and GTPases 
which are important for various biological consequences5, 6. The adhesion-mediated signals 
have high impact on various biological process that span survival, morphogenesis, 
differentiation, migration, proliferation and tissue formation.  The extracellular matrix around 
the cell is not static; instead, cells actively change the composition and activity of adhesion 
molecules by degrading, secreting and stretching it6. 
Current model systems (Petri dishes covered with proteins) have been successful in 
providing biologists tremendous amount of important information about these adhesion 
mediated biological consequences. However, in order to fully understand adhesion mediated 
biological processes in vivo, it is essential to have a more sophisticated model system which 
can closely mimic the cell adhesion environment. For example, current model systems are 
not optimized to mimic dynamic and non-homogeneous nature of the ECM. Furthermore, 
most of biological consequences are result of converged stimulations from adhesion and 
other soluble factor receptors. Well-defined control over cell adhesion will become a facile 
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tool to solve such intricately linked processes by quantifying contributions from each 
pathway as well as study the mechanism of cross-talk between them. Therefore, we 
developed a novel biological model system with facile, real-time and well-defined control 
over cell adhesion conditions, which can expand our knowledge of biology. 
 
1.1.1 Integrins 
 Integrins are major family of cell-surface-adhesion receptors, which are composed of 
two subunits (! and ß) forming non-covalently associated heterodimmers. Both subunits are 
type I transmembrane glycoprotein with relatively large extracellular domain and small 
intracellular domain. Until now, 18 ! and 8 " subunit genes have been reported forming 24 
different integrins (Figure 1.1)7, 8. The heterodimers bind to overlapping range of 
extracellular matrix molecules such as fibronectin, laminin, collagen, vitronectin or  
fibrinogen and cell surface counter-receptors such as cadherin, the Ig-superfamily proteins 
intercellular adhesion molecule–1 (ICAM-1) or vascular cell adhesion molecule–1 (VCAM-
1) providing mechanical support for adhesion9-11.  
 
1.1.2 Adhesion Complex 
Four kinds of adhesion structures have been discovered in mammalian cells including 
focal complexes, focal adhesions, fibrillar adhesions and 3D-matrix adhesions. Initially, cells 
make transient small contact structure at the leading edge or periphery of cell migration as a 
focal complex12. If the focal complex is stabilized and matured, it progressively becomes a 
focal adhesion then fibrillar adhesion.  
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The cell-matrix adhesion complexes are dynamic bi-directional signal transmitting 
nexii as well as mechanical conduits. The bi-directional controls span all the steps of 
formation and disassembly of the adhesion structures; activation of integrins, engagement of 
activated integrin and ECM molecules, co-localization of engaged integrins, and 
disengagement of integrins. The spatially and temporally regulated assembly and 
disassembly of adhesion structures composed of multiple proteins are formed at the 
cytoplasmic tail of integrins (Figure 1.2). 
 
 
Figure 1.1 Some of the 24 mammalian integrins for different adhesion molecules are 
depicted. Each of them has specific and non-redundant functions. Not only do the integrins 
have specific target for interactions, the knock out experiments showed distinct biological 
phenomena supports their unique roles7,8.   
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 In more detailed explanation, talin, one cytoplasmic component, binds to the integrin 
tail and  increases affinity of the receptor to specific ECM ligands by reorganizing the 
ectodomain. Currently it is believed, talin interacts with cytoplsmic tail of beta integrin to 
disrupt the self-inhibitory interaction between ! and " integrins. Talin mediates the initial 
connection between the ECM and cytoskeleton, which help transfer mechanical signals to 
stabilize and recruit other protein components. When the mechanical forces generated from 
ECM or internal actomyosin contraction is applied on the ECM-integrin-cytoskeleton 
complex, a focal complex matures into a focal adhesion connected to bundles of actin fibers 
called stress fibers13, 14. Then, the mature focal adhesion complex further recruits cytoplasmic 
components related to downstream signaling propagation. These signaling events are surface 
ligand dependent.  
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Figure 1.2 The major signal pathways and components are depicted for focal adhesion 
complexes. Many biological consequences on cell behaviors mediated by cell adhesion are 
often in concert with G protein coupled or kinase receptors for soluble factors. The link 
between signaling and receptors happen at the sub-membranous adhesion complex 
beneath the clustered complex.  
 
1.1.2.1. Focal Adhesion Kinase and Src-family Kinases  
Focal adhesion kinase (FAK) acts as a scaffold for phophorylation mediated signaling 
generated at the adhesion complex. FAK has several domains for interaction with specific 
partners; 1. FERM domain for cytoplasmic tail of integrin and growth factor receptors, 2. 
Focal adhesion targeting (FAT) domain for Paxillin and 3. others region for SH2 and SH3 
domain. FAK is non-receptor tyrosine kinase, which responds to the clustering of integrins 
by autophosphorylation. Once phosphorylated, the domain is now available to the kinases 
containing SH2 domains, like Src kinases, which then become activated and phosphorylate 
FAK to increase its kinase activity. The activated FAK (FAK-Src complex) is then able to 
interact with more proteins having SH2 and SH3 domains. These proteins are important in 
subsequent kinase and GTPase signaling for cytoskeletal organization, proliferation, survival, 
conversion of adhesion structure, motility, bi-directional mechanotransduction and gene 
expression.14 
 
1.1.2.2 Integrin-Linked Kinases (ILKs)  
Integrin-Linked Kinases, a serine-threonine kinase, are signaling and scaffolding 
proteins, which are found in adhesion structures15. The ILK, associated with " integrin 
cytoplasmic domain, regulates cell proliferation, survival, migration and Phosphoinoditide 
3-kinase (PI3 kinase) -dependent signal transduction16. It has been shown that the interaction 
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between ILKs and PINCH, paxillin, and parvin is important in regulation of cell adhesion 
and migration15. The ILK contains a N-terminal domain (ankyrin-repeat) for PINCH 
proteins and C-termial domain (kinase domain) for parvin proteins, paxillin and " integrin 
tail16. The heterotrimeric complex of ILK, PINCH and parvin (paxillin binding protein) acts 
as a hub for integrin signaling network, similar to FAK. 
 
1.1.2.3 Paxillin  
Paxillin, with no kinase activity, is also signal scaffold protein for signal transduction. 
It assembles into the adhesion complex at early stage and recruits more components. Paxillin 
has numerous phosphoylation target sites for extra control for protein-protein interactions. It 
also has many protein-protein interaction modules such as leucin-rich repeat, proline-rich 
region and LIM domain for further interactions with kinases (FAK, ILK and Src), 
phophatases (PTP-PEST), structural proteins (vinculin and parvins) and regulator and 
effector of Rho GTPases (CrkII-DOCK180-ELMO complex)17.  
 
1.1.2.4 Vinculin 
The vinculin is a structural protein, which connects cytoskeleton and the adhesion 
complex. It interacts with talin, F-actin, paxillin, VASP and Arp2/3, which regulate actin 
polymerization and the structure of adhesion complex18.  
  
 
1.2 SENSING BIOLOGICAL CONTEXT: INTEGRIN-MEDIATED 
SIGNALING PATHWAYS 
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The engagement of integrins to ECM molecules and subsequent co-localization is 
related to various signal transduction associated with other receptors (e.g., G protein-coupled 
receptor and receptor kinases) controlling proliferation, apoptosis/survival, shape, polarity, 
motility, differentiation and transcription. It has been well known that cells have anchorage 
dependent response to soluble growth factors such as EGF, PDGF, LPA and thrombin, etc. 
which are essential for survival and proliferation. These integrin-mediated growth factor 
signals are well characterized for normal cells; blocking apoptosis via PI3-kinase and Akt 
and stimulate cell cycle progression via ERK and cyclin D119, 20. For this, FAK may act as a 
signal converging point since the kinase can be activated by soluble growth factors and 
integrin co-localization20. In addition, integrin-dependently activated FAK can recruit 
several adaptor proteins, which activate downstream signaling mediators previously 
implicated in growth control, including Src, Ras, and Raf21.  
 
1.2.1 Cross-talk With Receptor Tyrosine Kinase at the Adhesion Complex.  
FAK may act as a mediator for cross-talk between integrin and receptor tyrosine 
kinase. Several experiments showed the adhesion complexes include not only integrins but 
also growth hormone receptors. In more detail, Plopper et al. used microbeads which were 
modified by minimum cell binding ligand of fibronectin, Arg-Gly-Asp (RGD), to induce 
integrin activation and formation of adhesion complex which included receptors for basic 
fibroblast growth factor (bFGF)22, 23. Similarly, Miyamoto et al. showed that receptors for 
platelet-derived growth factor (PDGF) and epidermal growth factor (EGF) are also 
incorporated in the adhesion complex24. The recruitment of growth factor receptors results in 
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the activation of the growth factor receptors and accumulation of downstream signal 
components and eventually increment of mitogen response25.  
 
1.2.2 Cross-talk at the level of mitogen-activated protein kinases (MAPKs) cascade 
pathways: Parallel and independent controls by integrin and growth factor receptors.  
Mitogen-activated protein kinases (MAPKs) are serine/threonine-specific protein 
kinases which respond to external signals, such as mitogens, osmotic stress and heat shock 
to regulate various cellular activities; gene expression, mitosis, differentiation, proliferation 
and survival/apoptosis25. 
The MAPKs are regulated by phosphorylation cascade, which consists of 3 kinases. 
External signal activates MAP kinase kinase kinase (MAPKKK, MAP3K), which activates 
MAP kinase kinase (MAPKK, MAP2K) and MAP kinase (MAPK). This MAPK cascade not 
only conveys an upper signal to downstream effectors but also amplifies and coordinates 
with other signals. The cascade diversifies the response pattern, which make it an important 
downstream cross-talk mediator for cell surface receptors.  
  Both integrins and growth factor receptors are involved in control of MAPK cascade, 
sometimes, by separate and different mechanisms26, 27. It is also known that the activation of 
MAPK by both receptors synergistically act on the activation of MAPK pathway together 
with FAK. However, the contributions of the two activation mechanisms onto the signaling 
pathways are very difficult because of intimate association of signaling by integrin and 
mitogen. Considering this, more facile and sophisticated control for the cell adhesion model 
surface must be used to resolve the multivariate equation.  
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1.2.3 Cross-Talk at Rho GTPases level  
Rho GTPases, such as RhoA, Rac1 and Cdc42, are subfamily of Ras superfamily and 
act as a small biological switch molecule (~20kDa). They are essential upstream regulators 
in control of various cellular behaviors, such as cell adhesion, migration, gene expression, 
actin polymerization and cell polarization28. The activated GTPase (GTP bound form) can 
interact with various signaling components and convey signal to downstream effectors. 
When the bound GTP is hydrolyzed to GDP, the GTPases are inactivated. The guanine 
nucleotide exchange factors (GEFs) move equilibrium to GTP bound status of the GTPases 
(‘on’ status) by facilitating the exchange of hydrolyzed GDP with GTP; while GTPase 
activating factor (GAP) facilitate the hydrolysis of GTP to GDP turning off the molecular 
switch.  
 
1.2.3.1 Cdc42 
Cdc42 conveys external signals from integrin, growth hormone reactor and G-
coupled protein receptors (GPCR) to various effectors. Cdc42 is inhibited in the complex 
with RhoGDI until it is released from the Cdc42-RhoGDI complex by Cdc42-GDI kinase. 
Cdc42 can then be localized to the membrane and interact with SCAR and WASP regulating 
cytoskeletal organization and actin polymerization, MAPKs regulating cell growth, survival, 
apoptosis and differentiation, or PAK1/MLCK/Myosin to activate myosin29-31. 
 Cdc42 also has role in regulation of cell behaviors like polarization by affecting the 
microtubule assembly and gene transcription32. It had been shown that inhibition of Cdc42 
in macrophage blocks its chemotactic ability, while maintaining its ability to migrate33.  
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1.2.3.2 Rac1 
Rac1 is most well studied among the Rac proteins, Rho GTPases subfamily (Rac1-4). 
Rac1 also can convey signals from integrin, growth factor receptors and GPCRs to the 
downstream effector molecules. Similar to Cdc42, Rac1 needs to be released from Rac1-GDI 
complex by Rac1-GDI kinase and localized to membrane by isoprenylation34-36. It has been 
shown that Rac1 regulates the cell protrusions. Miroinjection experiments showed that 
constituently active Rac1 increased membrane ruffling and lamellipodia extentions. Among 
three other Rho GTPases, Rac1 is the primary Rho-GTPase responsible for regulating the 
cytoskeletal remodeling involved with lamellipodia dynamics37-39. There are two distinct 
pathways to activate Rac1 from external stimui; PI 3-kinase and PI(3,4,5)P340 and 
p130Cas/CrkII/DOCK180 pathways41,42. 
 
PI 3-kinase and PI(3,4,5)P3. PI 3-kinase pathway has been shown to activate Rac1. The 
increased intracellular concentration of Phosphatidylinositol (3,4,5)-trisphosphate (PIP3) by 
microinjecting constituently activated PIP2 kinase lead to vigorous lamellipodia protrusions 
and membrane rufflings which mediated by up-regulation of GTP bound Rac140. This is 
thought to be localization and translocation effect at the membrane for the GEFs having 
plecktrin domain (PH domain). All Dbl family of GEFs have PH domain, which can interact 
to PIP3 lipid at the membranes.  
 
p130Cas/CrkII/DOCK180 pathway. DOCK180 is a GEF, which can act as a complex with 
two other proteins (p130CAS, CrkII) to catalyze the exchange of the GDP to GTP for Rac 
proteins. It was shown that the complex can activate Rac and promotion of cell migration41, 
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42. 
 
1.2.3.3 RhoA 
RhoA is a member of the Ras homology family of small GTPases.  RhoA has been 
well characterized as important biological switch in regulation for the polymerization and 
rearrangement of actin cytoskeleton. However, further research has revealed more functions 
such as myosin chain elongation, gene expression, cell morphology decision, and 
proliferation43, 44. Even though there are many stimuli to activate RhoA, such as growth 
factors, cytokines, adhesion molecules, and hormones, G-Protein coupled receptors (GPCR) 
are a major activator for RhoA. For example, when ligands are bound to IGF1/2 and IGF1R 
(insulin-like growth factor I receptor), a complex is formed with Leukemia-associated 
RhoGEF-12 (LARG), which then activate RhoA45-47.  
 
 
1.3 GTPASES AND CELL BEHAVIORS: MIGRATION 
 
In section 1-2, 3 representative levels of cross-talk between adhesion and soluble 
factors, which are essential for basic biological activities of cells, were shown: the adhesion 
complex, MAPK cascade, and GTPases. In this section, what effectors exist under GTPases 
and how the GTPases regulate biological phenomenon, especially migration and protrusions, 
will be described. Those behaviors associated with GTPases activities were observed for the 
cells on our engineered cell adhesion model surfaces. 
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Figure 1.3 The coordinated series of steps for migration are depicted. Initially, Cdc42 
regulates the direction of migration. Then, Rac takes part in actin polymerization and 
formation of adhesion structure at the front of cell leading edge. Finally, Rho regulates 
actomyosin contraction in cell body to promote movement, turnover of adhesion complex 
and rear retraction. 
 
1.3.1 Lamellipodia Extensions 
 Lamellipodia are cellular feet-like protrusions essential for cell migration. They seek a 
new adhesion site to help propel the cell forward. The requirement of Rac proteins for 
lamellipodia extensions and cell migration had been well supported by research. They 
demonstrated that cell could not extend lamellipodia and migrate responding to adhesion to 
ECM molecules, growth factors and cytokines when the Rac is mutated48-50.  
  It was shown that the formation of lamellipodia accompanies formation of branching 
out of actin filament flank using actin-nucleating activity of Arp2/3 complex51(Figure 1.3). 
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First, Rac interacts with IRSp53, which has SH3 domain for further interaction with WAVE, 
which then activates Arp2/3 complex52. The IRSp53 has separate domains to interact with 
Cdc42 and Dia1, a target protein of Rho, enabling Cdc42 and Rho induced Rac-dependent 
lamellipodia extentions53, 54.    
 Rac can also stimulate actin polymerization by removing cap protein at the (+) side of 
barbed end on actin fiber55, 56. Rac is also involved in the stability of actin fibers by LIM 
kinase mediated inhibition of cofilin57, 58. The Rac/Cdc42 target protein PAK activates LIM 
kinase, which then inactivates cofilin, a protein that promotes actin depolymerization58.  
These studies all indicate that Rac is a key regulator of migration because of its ability to 
stimulate lamellipodium extension. 
 
1.3.2 Turnover of Adhesion Complex 
 Rac is needed for the formation of small adhesion structures (focal contacts) at the 
periphery of lamellipodia of migrating cells that are important for creating new attachment 
during migration59-61. This focal contact is transient and Rho should act to mature the 
structure61. Therefore,  an increase in Rho activity leads to stronger adhesion decreasing the 
migration rate62. Rac induces the disassembly of adhesion structures directly through PAK 
pathway63 or indirectly through antagonizing effect on Rho64. PAK interacts with component 
of focal complex/adhesion, like paxillin, to be co-localized into the adhesion structure, and 
then induces disassembly by phophorylating its effectors63. Since the disassembly by Rac-
mediated PAK is dependent on integrin interactions, it is thought that certain critical amount 
of integrin engagement may trigger PAK induced disassembly of the adhesion complex65. 
Aside from Rac mediated disassembly, FAK and Src can signal for disassembly of the 
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structures66. Furthermore, it was shown that microtubules can target the adhesion structures 
and transport proteins for disassembly.67  
  
1.3.3 Cell Body Contractions 
 Cell body contraction is required for cell migration to drag the cell body toward a 
newly formed cellular grip while facilitating detachment from previous adhesion sites. This 
cellular contraction is driven by contraction of actomyosin, a complex between actin and 
myosin68 and has been shown that Rho is important in inducing the actomyosin contraction69. 
Rho regulates the phosphorylation of myosin light chain (MLC) enabling contraction by 
activating ROCK (Rho-kinases), directly phophorylating MLC and inactivating MLC 
phosphatase70, 71. Similar to PAK, as described previous section, ROCK also activates LIMK 
to inactivate cofilin, leading to the accumulation of actin fibers72, 73. Rho is also related to 
activation of Dia, which interacts directly with Src kinases for its effect on stress fibers74.  As 
previously mentioned, the Dia proteins can interact with IRPsp53 and interact with WAVE to 
induce actin polymerization.   
 
1.3.4 Filopodia Extention 
 Filopodia are actin-rich protrusions from plasma membrane, which form new adhesions 
for migration as well as antennae for cells to probe environment around them. The functions 
for filopodia are important in cell migration, neurite outgrowth and wound healing75. Cdc42 
initiates the actin polymerization by interacting with WASP, which activates Arp2/3 
complex76-78 (Figure 1.3). RIF (Rho in Filopodia) can induce filopodia protrusions by 
activating Dia2 (diaphanous-related formin-2). Dia2 promotes nucleation and elongation of 
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linear F-actin to make longer filopodia than Cdc42 induced filopodia79.  
 
 
 
Figure 1.4 A schematic view of actin polymerization, rearrangement, and upstream 
regulator GTPases are depicted: Rac controls lamelipodia and focal complex formation; Rho 
controls stress finer bundles and focal adhesion development; Cdc42 controls filopodia and 
focal complex formation. The lamellipodia formation is dependent on branching of new actin 
fibers by Arp2/3 complex. Rac activates WASP or WAVEs then they activate Arp2/3 
complex. Cdc42 induces actin polymerization by either direct interaction with WASP or 
IRSp53 Tyr kinase – Arp2/3 pathway. Cdc42 and Rac also induce actin polymerization by 
activating PAK and LIMK, which phosphorylates cofilin inhibiting depolymerization of actin 
fibers. Rho activates MLCK which phosphorylates the light chain of myosin enabling 
actomyosin contraction and stress fiber formation. This mechanical stress imposed on the 
adhesion complex stimulates maturation to a focal adhesion.  
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1.4 FIBRONECTIN 
 
Fibronectin (FN) usually exist as a dimer of identical subunits (~250kD) with a 
disulfide bond at near C terminus. Each FN homodimer consists of 3 different types of 
repeating units (FN I, FN II and FN III); 12 FN I, 2 FN II and 15~17 FN III repeating units.  
Twenty different types of FN are generated from a single gene by alternative 
splicing80, 81. This ability to generate multiple variants of FN is important for producing 
tissue specific FNs having specific cell-adhesive, ligand binding, and solubility properties. 
For example, 2 different classes of FNs exist based on solubility; cellular FN which (cFN)  is 
less soluble and plasma FN (pFN), a more soluble form.  The isoforms of FN are important 
mechanism in tailoring the ECM environment around cells in spatio-temporal manner by 
modulating which isoforms are present. 
FN, not only interacts with many ECM molecules, but it interacts with at least 12 
integrins, acting as main linker between the ECM and intracellular cytoskeleton. The 
minimum cell binding domain is located at 10th FN III as 3 amino acid sequence (RGD)81. 
PHSRN at 9th FN III was also characterized as a synergistic cell binding site for !5"181. The 
!5"1 integrin can also interact with N-terminus of FN conveying distinct signals from RGD-
integrin interactions. Integrins other than !5"1 were reported to interact with FN. The !4"1 
integrins are reported to interact with REDV, LDV, IDAPS, KLDAPT and EDGIHEL 
sequence, !4"7 can interact with REDV and LDV, and !9"1 integrins can interact with 
EDGIHEL82. FN also interacts with other ECM molecules. FN has two heparan sulfate 
proteoglycan interacting domains near C- and N- terminus, two domains for collagen 
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interaction in FN I 6~9 and FN II 1~2, and two fibrin interacting domains (Fibrin I and 
Fibrin II)83.  
 
 
1.5 Dynamic Cell Environment 
 
Cells actively modify their environment by secreting enzymes, cell-binding 
molecules, as well as controlling bi-directional mechanical tension across the adhesion 
complex. For example, lysyl oxidase is a cell-derived enzyme, which cross-links elastin and 
collagen associated with fibroblasts.84, 85 The cross-linking is essential for forming an 
insoluble collagen, and elastin fibers control matrix porosity and normal mammalian 
development.  
The adhesion complex is bi-directional molecular clutch, which modulates 
mechanical tension across the cell membrane.86 For example, the actomyosin driven cell 
migration transfers endogenous tension caused by actomyosin contraction to the ECM 
engaged adhesion complex. This stretching process increases exogenous tension of cell 
binding molecules such as fibronectin, and reveals hidden cross-linking sites where other 
ECM molecules can associate.87, 88 Furthermore, cells actively remodel the ECM 
environment by secreting matrix metalloproteinases (MMPs) responding to stimuli like 
injury. The activity of MMPs is tightly controlled under normal conditions, which is 
important for development, morphogenesis, tissue repair, and remodelling.89 Many kinds of 
MMPs including Collagenases, Gelatinases, Stromelysins and Matrilysin exist. Among 
them, collagenase uncoils the triple helix of collagen fibril, so that susceptible proteolysis 
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sites are exposed increasing porosity of ECM meshworks.90 However, MMPs activity 
increases in the case of several diseases, which rapidly remodels the local ECM.  
 
 
1.6 SAMs on Gold as a Platform for Cell Biology 
 
Self-assembled monolyaers (SAMs) are monolayer films of molecules that form 
spontaneously on solid surfaces. This spontaneous organization is driven by 
thermodynamically favorable interactions between the molecules, surface, as well as inter-
molecular forces.  
Among many kinds of SAMs, alkanethiolates on gold have been studied extensively 
because of several inherent advantages. The gold-thiol bond forms quickly and gold resists 
oxidation well compared to the other noble metal based SAMs. Thiols are synthetically 
flexible to allow for the creation of a variety of surfaces. Specifically, SAMs of olgio 
(ethylene glycol) are inert to non-specific adsorption of proteins and the bond is stable for 
weeks when in contact with cell culture media.  Also, many characterization methods are 
available for SAMs on gold, such TEM and SPR. 91, 92. These advantages of SAMs on gold 
allow for the control of the interfacial physical properties to study fundamental aspects of 
SAMs93, 94. Many efforts to characterize the properties of alkanethiolate SAMs on gold prove 
the monolayer is well ordered with well-oriented terminal groups and the kinetics of film 
formation follow the Langmuir isotherm.  
 
1.6.1 Chemisorption of Alkanethiols onto the Gold Surface 
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  Several X-ray photoelectron spectroscopy (XPS) studies showed that alkanethiolates 
are formed after adsorption onto the gold surface95, 96. IR and Raman spectroscopy could not 
observe the S-H stretching vibration either97-99. Laser desorption Fourier transform mass 
spectroscopy also found out that significant amount of thiolate negative ions was desorbed 
from the surface100, 101.  
 SAM formation can be considered formally as oxidative addition of the S-H bond to 
the gold surface, then followed by a reductive elimination of the hydrogen: 
 
RSH + Au(0)n " RS–Au+#Au(0)n-1 + 1⁄2 H2 
 
Bond energies for each component of equations are RS-H (87 kcal mol-1),  H-H (104 kcal 
mol-1), and RS-Au (40 kcal mol-1). The net energy for adsorption of alkanethiolates on gold 
is -5 kcal mol-1. Therefore, the reductive removal of hydrogen atoms at the surface yielding 
H2 molecule is the most important exothermic step in the overall reaction102.  
 
1.6.2 SAM Formation on the Gold Surface Follows Langmuir Isotherm 
The kinetics of SAM formation on the gold surface were extensively characterized by 
ellipsometry, XPS, surface acoustic waves, second harmonic generation and low-energy 
electron diffraction (LEED) to show it follows Langmuir adsorption model. Two kinetic 
steps are involved in formation of SAMs; the quick adsorption of molecules onto the surface, 
followed by the slow crystallization process through motion and extra adsorption of 
molecules. Typically, a well-ordered SAMs can take days to form and its surface density is 
~4.5 x 1014 moelcules/cm2 103.  
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1.6.3 Structure of Monolayer on the Gold Surface (111) 
 Electron diffraction experiments as well as scanning tunneling microscopy (STM) 
showed the monolayers of alkanethiols on a gold lattice (111) form (#3 x #3)R30° overlayer 
structure104-106 (Figure 1.5). The distance between thiolate groups is 4.99 Å while the closest 
distance between alkyl chains induced by van der Waals is 4.24 Å. The tilting of alkyl chain 
maximizes the van der Waals interactions between two chains107. 
 
Figure 1.5 A hexagonal coverage of alkyl thilos on Au(111) surface. The alkyl chains are 
close-packed by Van der Waals interactions. The difference between thiol-thiol distance and 
Van der Waals distance tilt the chain approximately 30° from the normal to the surface to 
maximize the interaction. 
   
1.6.4 SAMs on a Gold Surface as a Novel Biological Models System 
 With unique advantages as a biological model system, SAMs have been applied to 
study various aspects of cell adhesion and migration108, 109. The unprecedented control at the 
molecular level was harnessed to mimic the dynamic ECM, where the presentation, 
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composition and distribution of cell binding ligands are constantly changing.  
 Liu et al. showed that RGD, a cell-binding peptide, presented over non-fouling SAMs 
could be hidden by illuminating light on to an azobenzene SAM110. The azobenzene adjacent 
to RGD peptide switched between its diastereomeric E and Z isomers; 450-490 nm for E 
configuration and 340-380 nm for Z configuration. The Z configuration of the azobenzene 
hid the RGD peptide into the inert layer of poly(ethylene glycol) (PEG), losing cellular 
accessibility110. This system allowed them to switch cellular adhesion on the surface by 
illuminating light of different wavelengths. Yeo et al. introduced similar dynamic surface 
where cell adhesion is switched by releasing the cell-binding molecule, RGD111. They 
harnessed electroactivity of hydroquinone and its instant formation of cyclized lactone upon 
electrochemical reduction, releasing previously propionic acylated peptide tethered to the 
quinone group. Other approaches using various molecular controls have been used to create a 
dynamic surface112-114.  
 The most common surface patterning technique, micro-contract printing (µCP), 
allowed the patterning of alkanethiolates on gold. To perform the procedure, elastomeric 
stamps inked with a hydrophobic alkanethiol were gently pressed onto the gold surface to 
generate a hydrophobic domains, which were later backfilled by non-fouling molecules (TEG 
terminated alkanethiol). Then, the hydrophobic domains were selectively modified to allow 
cell adhesion in pattern115. 
  Maduram et al. applied this method to observe cellular responses to different geometric 
cues in 2D tissue116. Similarly, Xia et al. introduced nanopatterns of Fn to show 
corresponding cellular responses of intracellular signaling (Rac) and focal adheiosn 
formation 117. Luo et al. showed the effect of geometry and cell culture size on the rate of 
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stem cell differentiation118. Hoover et al. created nano arrays of RGD peptides with dip-pen 
nanolithography (DPN) to show the correlation of ligand binding affinity and asymmetric 
distribution for cellular orientation119, 120.  
 There have been many efforts to create surface ligand gradients on SAMs to study 
haptotaxis. Chan et al. introduced gradient of RGD peptide by photodeprotection through a 
gradient mask to show cellular preference of ligand density as well as directed migration 
along the axis to the higher density of RGD. Lamb et al. further introduced larger scale 
gradients by µCP121, 122. This method harnessed percolation of alkanethiols from PDMS 
microfluidic channels followed by subsequent stamping onto the gold substrate.  
  
  
1.7 BIO-ORTHOGONAL CONJUGATION 
 
Countless biological molecules and ions exist in the cytoplasm, interacting for a 
number of different functions; activating or deactivating counterparts, becoming a complex 
to converge and diverge signals, and manipulating different biopolymers. Methodologies for 
transport characterization, localization, and biological changes for certain components in vivo 
are important since they often act differently from in vitro. In other words, target 
biomolecules need to be tagged with a probe, which can be monitored non-invasively in a 
living cell.  
 Without a doubt, genetic tagging with a fluorescence probe (GFP and its variants) to a 
target protein has been most the widely used methodology123-126. However, genetic tagging 
has its limitations. It cannot be applied to other kinds of biomolecules, such as carbohydrates, 
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nucleic acids and lipids. In order to overcome these problems, bio-orthogonal chemistry has 
emerged as general tagging method for non-protein biomolecules. Bio-orthogonal reactions 
must be invisible to biological functional groups (bio-orthogonality), mild and occur close to 
physiological conditions for cell survival (aqueous, pH7.4, 37°C), robust, fast, and high 
yielding at low concentrations, non-cytotoxic, and products must be stable in the cell. A few 
reactions satisfy these tough criteria, and the representative reactions will be described 
below. 
 
1.7.1 Staudinger Reaction 
 Hermann Staudinger reported in 1919 that azides react with triphenylphosphine under 
mild conditions to produce an aza-ylide intermediate. In the presence of water, the 
intermediate is subsequently hydrolyzed to yield two products: an amine and corresponding 
phosphine oxide127, 128. Noting the bio-orthogonality of the azide and phosphine group, and 
the mild reaction conditions, the Bertozzi group utilized this reaction as a ligation strategy129. 
They installed an intramolecular electrophile trap next to phosphine group, so the result of 
the reaction is amide and phosphine oxide formation, known as a Straudinger ligation (Figure 
1.6). Even though the oxidation of phosphine by air or metabolic enzymes was a potential 
problem, this ligation methodology was successful in fulfilling several needs for bio-
imaging130-132. Soon after this report, several efforts to improve the ligation methodology by 
remove the auxiliary phosphine from final ligation products were undertaken. In this 
traceless ligation, the phosphine group is linked to nucleophile, which is then acylated by the 
carboxyl group of molecule A. If the azide-containing molecule B is introduced, the aza-
ylide intermediate attacks acyl group and hydrolyzes to produce amide and phosphine oxide 
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without side products133-135. Although the traceless Staudinger ligation has not been used in 
living cells, it has been applied to immobilization of molecules onto the surfaces136.  
 
1.7.2 1,3-Dipolar Cycloaddition 
Huisgen first reported the scope of reactions between activated alkyne and azide as a 
1,3 dipole137. The activation was achieved by adding an electron-withdrawing group, like an 
ester, to the alkyne resulting in $,%-unsaturated carbonyl structure. If there was no activation 
of alkyne, the reaction mixture needed to be boiled to obtain the conjugated product. The 
Sharpless group reported that with the use of the catalyst, Cu(I), the rate of cycloaddition 
increases ~106 fold138, 139(Figure 1.7A). This Cu(I) catalyzed 1,3-dipolar cycloaddition 
reaction, also known as ‘click’ chemistry, happens at physiological conditions in the presence 
of cell lysate. In spite of the impressive thermodynamic stability of the conjugated product 
(30-35 kcal/mol), and fast reaction rate in physiological conditions, these reactions could not 
be used in cells because it lacks bio-orthogonality (activated alkyne can be a Michael 
receptor for various biological functional group) and the cytotoxicity of metal catalyst. 
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Figure 1.6 (A) Staudinger ligation (B) Traceless Staudinger ligation 
 
The Bertozzi group developed catalyst free 1,3-dipolar cycloaddition by introducing 
ring strain to the alkyne, which is now bio-orthogonal but activated enough for conjugation 
in physiological conditions without catalyst140 (Figure 1.7B). The alkyne located in the 8 
membered ring has ~18 kcal/mol strain which can be released when it forms intermediate of 
the [2+4] cycloaddition. Further activation of the alkyne by adding electron-withdrawing 
group (Fluorine), increased the second order reaction rate from 1.2 x 10-3M-1s-1 to 7.6 x 10-2 
M-1s-1 141. These strategies were successfully applied to various in vivo imaging. 
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Figure 1.7 (A) 1,3-Dipolar cycloaddition (B) Copper-free click chemistry 
 
1.7.3 Bioorthogonal Peptide Sequence 
 Tsien and coworkers have developed short amino acid sequence which act as a bio-
othogonal tagging target for special chemical moiety142, 143. They introduced 6 amino acid 
sequence containing 4 cysteins (CCXXCC, where XX can be any amino acid but proline and 
glycine yields optimal results) that react with biarsenicals (Figure 1.8). The peptide reporter 
is expressed by genetic modification and a cell-permeable chemical reporter is introduced 
later to form covalent bond under physiological conditions. The ethanedithiol substituents 
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protect the arsenic group from reacting with single thiols in vivo. This methodology has been 
applied as a supplement to GFP strategies, because GFP labeling sometimes perturbs proteins 
due to its size 144, 145. This methodology was further applied to protein tracking using FlAsH 
and ReAsH, staining for electron microscopy146, attaching small molecule to protein147-150, 
and labeling with small-molecule binding peptide 151-153.   
 
Figure 1.8 Bio-orthogonal peptide sequence for chemoselective conjugation 
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2.1 INTRODUCTION 
 
 
Many cell biological consequences, such as survival, proliferation, differentiation, 
polarization, migration, apoptosis, and gene expressions require stimuli from upstream 
adhesion receptors like integrins and growth hormone receptors1,2. When integrins engage 
ligands, they co-localize and eventually form adhesion complexes at the cytoplasmic tail that 
act as a bidirectional signal-mediating centers3,4. Since the adhesion structure often involves 
growth factor receptors, the complex is an important signal convergence point and the 
adhesion receptor is thought to provide environmental context for the cells translating other 
extracellular signals5,6,7,8. The focal adhesion complex, MAPK cascade and GTPases often 
contribute to converging signaling levels through independent mechanisms, but it is not 
trivial to assign their contributions without a proper biological model system. 
The interaction of cells with extra-cellular matrix (ECM) proteins such as fibronectin 
(FN) play a crucial role in various biological processes, including cell survival, proliferation, 
migration, differentiation, and apoptosis9-11. Many cell types bind to specific central cell 
binding domains of FN spanning from the 8th to the 10th type III domain (FIII8-10). 
Pierschbather and Ruoslahti reported that the short peptide sequence Gly-Arg-Gly-Asp-Ser 
(GRGDS) in the FIII10 domain is a minimum cell adhesion site12. However, FIII9 acts as a 
synergy site for interaction with integrins $5%1 and $IIb%3 to mediate cell adhesion and is 
necessary for obtaining maximal cell-binding activity. Later, PHSRN was isolated as the 
minimum synergistic sequence enhancing cell adhesion, although it was believed to be 
incapable of supporting attachment alone13,14.  
However, recent work has shown that PHSRN may have more functions than 
initially believed. Garcia et al. have suggested a model of $5%1-mediated adhesion of K562 
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erythroleukemia cell15. The integrins first bind to RGD, which modulates the integrin 
orientation, conformation, and activates them. Once activated, the integrins then bind 
PHSRN. Direct measurement of the binding force showed substantial mechanical force 
between $5%1 integrins and PHSRN. Furthermore, Feng and Mrksich have reported that 
PHSRN can act as a weak cell binding ligand using a self-assembled monolayer (SAM)16 
model system. The authors showed that several cell lines bind biospecifically to the PHSRN 
ligand via $5%1 integrins. Livant et al. have shown that acetylated and amidated soluble 
PHSRN has a surprisingly high activity in changing keratinocytes into their invasive 
phenotype17. These results strongly suggested that PHSRN may interact with cellular 
receptors and have its own biological effects outside of synergistic RGD mediated cell 
adhesion.  
In this paper, we compared cellular phenotypes mediated by functionally decoupled 
RGD and PHSRN using our novel model system. We engineered our model system for cell 
adhesion using self-assembled monolayers (SAMs) composed of 1:99 hydroquinone tethered 
alkanethiolate (HQ) / tetra(ethyleneglycol) alkanethiol (TEG) SAMs on gold surfaces 
(HQ/TEG system). With facile ligand immobilization to the chemically defined surfaces and 
the biospecific interactions between cell and ligands, HQ/TEG system has been successfully 
applied as simplified biological model system for cell adhesion, migration, intracellular 
nanoarchitecture formation, cell polarization, and differentiation18-22.  
Similar to the previous reports of Feng and Mrksich16, PHSRN demonstrated its!
potency as a cell binding ligand. We further compared cell phenotypes between two different 
ligand presenting surfaces, studying cell migration rate, membrane ruffling, and cytoskeleton 
arrangement. These results show PHSRN may induce different downstream signaling from 
 41 
that of RGD, which was proved by a GTPase pull-down assay with or without serum 
stimulus. Furthermore, we could modulate such cellular phenotypes of 3T3 fibroblasts by 
controlling the ratio of two ligands on the surface. These results demonstrate the HQ/TEG 
system can be a valuable addition to the tool set of cell biology research, especially in 
studying cross-talk between adhesion and growth factor signals.  
 
 
2.2 EXPERIMENTAL 
 
2.2.1 Substrate Preparation and Cell Culture Condition  
 
Substrate preparation. Gold substrates were prepared by electron-beam deposition of 
titanium (3 nm) and then gold (12 nm) on glass microscope slides using a vacuum evaporator 
system with a 3kW electron beam gun (Model VE-100, Thermionics Laboratory, Inc., Port 
Townsend, WA). In order to form a SAM, newly coated substrates were first washed with 
absolute ethanol and then immersed into a 1mM ethanolic solution of alkanethiolates (1:99 
HQ/TEG) for at least 12 hours. The molecules are synthesized as previously described51. The 
hydroquinone-containing surfaces were oxidized by applying a potential of 750mV (vs. 
Ag/AgCl) for 15 seconds in a 1 M solution of HClO4 using a BAS 100B/W Electrochemical 
Analyzer (Bioanalytical Systems, Inc., West Lafayette, IN). Ligands were immobilized by 
immersion into the corresponding oxyamine-peptide solution (10 mM in PBS) for 4 hours. 
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Cell culture. 3T3 Swiss Albino (SA) mouse fibroblasts were cultured in Dulbecco's modified 
Eagle's medium (Sigma) with 10 % bovine calf serum and 1 % penicillin/streptomycin (37 
°C in a humidified 5% CO2 atmosphere). In order to plate cells onto the SAM substrates, 
cells were removed from the culture flask with a solution of 0.05% trypsin/0.53 mM EDTA, 
re-suspended in serum-containing or serum-free culture medium (5,000~10,000 cells/mL), 
and seeded for 2 hours. The cell suspended solution was then removed and the substrates 
were further cultured in fresh serum-containing or serum-free media. 
 
2.2.2 Characterization for Cell Behaviors  
 
Fluorescence imaging and cell area measurement. For imaging and data processing, cells 
were fixed with 3.2 % formaldehyde in PBS and then permeated with PBS containing 0.1 % 
Triton X-100. A fluorescent dye mixture containing DAPI (4 ,6-diamidino-2-phenylindole 
dihydrochloride, neucleus; Sigma), phalloidin-TRITC (tetramethylrhodamine B 
isothiocyanate, actin; Sigma), and anti-paxillin (BD Biosciences, San Jose, CA) with a 
secondary fluorescently labeled antibody (Cy-2 conjugated goat anti-mouse IgG, Jackson 
ImmunoResearch Laboratories, Inc., West Grove, PA). In conducting cell area 
measurements, images were taken at 10 different random spots of each substrates and further 
analyzed by cell scoring mode from Metamorph software. A Nikon Eclipse TE2000-E 
inverted microscope (Nikon USA, Inc., Melville, NY) was used to obtain fluorescence 
images.  
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Migration rate determination. 3T3 SA fibroblasts were seeded onto prepared substrates at 
low concentration (1,000 ~ 5,000 cell/mL) to minimize the effects of cell-cell contacts. After 
incubation for 2 hours in cell culturing conditions, movies were taken for 20 hours 
(brightfield mode). Cell displacements at each hour were tracked by Metamorph program. 
 
Scanning electron microscopy. Cells were cultured 10 hours and dehydrated in a 50, 70, 95% 
and 100% EtOH/H2O series followed by critical point drying. A Pd/Au alloy (Cressington 
108 auto sputter coater, Cressington Scientific Instruments Ltd.) was deposited (~1 nm) onto 
the samples and the surfaces were imaged using a Hitachi model 2-4700 scanning electron 
microscope. 
GTPases activity assay. Cells were incubated in 0.5% delipidated BSA (Sigma) or 1% serum 
containing media for 16 hours. After trypsinizing from the culture flask, the suspended cells 
were pelleted by centrifugation (1000rpm, 5min) and followed by re-suspension in 
corresponding cell culture media. The cells were plated onto SAMs substrates and incubated 
for 2 hours. The Rac1 pull-down assay was performed using assay kit purchased from Cell 
Biolab inc. (San Diego, CA) and carried out according to the supplier’s instruction.  
 
 
2.3 RESULTS AND DISCUSSIONS 
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Recently, a novel biological model system that utilizes SAMs of HQ/TEG on a 
conductive surface for cell biology studies was introduced18-22. The p-hydroquinone 
functional group was electrochemically converted to the corresponding quinone form, 
allowing immobilization of soluble aminooxy-terminated (-ONH2) ligands to the monolayer. 
The quinone oxime product is also redox active and has its own unique diagnostic 
cyclovoltammetric (CV) peaks like hydroquinone. This control provides real-time monitoring 
of the ligand immobilization reaction to the surface, as well as quantification for the ligand 
density. It also opens up spatial control by creative patterning methods. In combination with 
the anti-fouling molecule TEG, known to resist nonspecific protein adsorption, this platform 
enables the study of biospecific interactions between ligands and cells with homogeneous 
activity of the ligands23-26. For our studies, we have chosen to use SAMs composed of HQ 
mixed with TEG (1 : 99 = HQ : TEG) to compare biological effects of different integrin-
ligand engagement (RGD and PHSRN) to cellular phenotypes. The oxyamine tethered RGD 
and PHSRN ligands are immobilized to the surface through the general immobilization 
scheme in figure 1 (as well as figure S1 in supporting material) in order to generate defined 
bio-specific interactions between cell adhesion receptors and the ligands.   
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Figure 2.1 (A) Schematic view of engineered model substrate that presents two ligands 
from fibronectin biospecifically to cells is presented. RGD and PHSRN as well as mixed 
ligands in ratios (right box) are presented to the cells. This minimal model system for cell 
adhesion can easily control ligand concentration, activity, localization and gradual 
presentation. (B) The hydroquinone alkylthiolate (HQ) is electrochemically oxidized then 
conjugate to the oxyamine tetherd PHSRN or RGD peptides. The backfilling molecules, 
tetra(ethyleneglycol) alkanethiolate (TEG), allows biospecific interaction between cell 
adhesion receptors and ligands by preventing non-specific adsorption of proteins onto the 
engineered biological model system ( Figure S1 for actual chemistry ). 
 
 
2.3.1 Biological Activity of Ligands: Mixed RGD and PHSRN Loses Synergistic Effect. 
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Figure 2.2 Cell areas on different ligand presenting surfaces are measured at different time 
points after the cell seeding (R: RGD, N-G6-R: GPHSRN-G6-RGDS, N+R: mixed PHSRN 
and RGD(1:1), N: PHSRN). Error bars are standard deviation. At least 200 measurements 
were performed for each data. Cells on N-R shows highest activity for cell spreading while 
mixed ligands (N+R) could not mimic such activity, confirms that decoupled RGD and 
PHSRN looses synergistic effect. PHSRN can act as a cell binding ligand but, still, its activity 
is lower than that of RGD.  
 
 A series of experiments were performed in order to compare biological activity of 
RGD, PHSRN, mixed RGD and PHSRN (RGD+PHSRN), and glycine hexamer linked RGD 
and PHSRN (PHSRN-G6-RGD) by assessing cell spreading on each ligand presenting 
surfaces. 3T3 swiss albino fibroblasts were cultured on substrates presenting each ligand and 
cell area was measured at time points ranging from 10 to 65 min (Fig. 2). The glycine 
hexamer of PHSRN-G6-RGD was based on the natural distance between PHSRN, which 
allowed higher cell adhesion activity than RGD alone27. It was found that PHSRN-G6-RGD-
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presenting substrates induced the most cell-spreading. The mixed RGD and PHSRN cannot 
reproduce the cell spreading activity of PHSRN-G6-RGD. These results emphasize the 
importance of orientation and distance between the RGD and PHSRN sequences to have a 
synergistic effect in cell spreading. As reported by Feng and Mrksich, cells adhered and 
spread on the PHSRN-presenting SAM substrate16. However, cells spread slowest on the 
PHSRN presenting SAM, implying decoupled PHSRN is less active for inducing cell 
spreading compared to RGD.    
 
 
2.3.2 Different Morphology and Behaviors for Cells on PHSRN- and RGD- Presenting 
Surfaces 
 
Cytoskeleton and Focal Adhesion. In order to compare adhesion structures and actin fiber 
organization on two functionally decoupled ligands, cells were stained for vinculin (anti-
paxillin with Cy-2, green), nucleus (DAPI, blue) and F-actin (phalloidin, red) after 10 hours 
of culture on RGD- and PHSRN- presenting surfaces (Figure. 3). Cells adhered to RGD-
presenting surface had a rigid appearance with well-developed stress fiber bundles that filled 
the entire cytoplasmic region of the cell body. The focal adhesions at the end and periphery 
of stress fibers were observed as a dot or oval like shapes. On the other hand, cells on 
PHSRN formed less stress fiber bundles and had less adhesion structures.   
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Figure 2.3  Focal adhesion and actin fiber stain images for cells after 10 hours of culture on 
PHSRN (left) and RGD (right) presenting SAM substrate. Cells on the PHSRN show rounder 
shape with less stress fibers while cells on RGD has well developed stress fibers and rigid 
shape. Correspondingly, cells on the RGD has many adhesion complexes while cells on 
PHSRN have less number of definite adhesion structures (Green : paxillin, Red : actin, Blue 
: Nucleus; bar indicates 20µm). 
 
Migration Rate. In order to compare migration rate of cells on both surfaces, live-cell 
images were taken to evaluate cellular migration rates on RGD- and PHSRN- surfaces. The 
15h movies were started 2 hours after cell seeding onto each substrate in the presence of 
serum (10 % bovine calf serum/DMEM). The tracking of cellular migration by Metamorph 
software was used to calculate the cellular migration rate on both substrates; 15.1 µm/h for 
cells on PHSRN and 6.7 µm/h for cells on RGD surface (Figure. 4B). The images taken 
every 20 min showed the different migration rates resulted from different protrusion 
dynamics for lamellipodia and filopodia. Figure 4A shows that cells on RGD spread well and 
produced fewer protrusions, resulting in a rigid shape and relatively slow migration rate. 
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However, cells on PHSRN showed high protrusion dynamics, extending lamellipodia and 
filopodia 0.5 ~ 1 times of cell body length. These results showed the increased migration rate 
is related to the cellular lamelipodia protrusion dynamics on PHSRN.   
 
Figure 2.4 Protrusions of cells on the surface presenting PHSRN (A, up) or RGD (A, down) 
were recorded by live cell imaging (Images were taken every 20 minutes). Cells on PHSRN 
surface showed highly dynamic protrusions. (B) Cell migration rate is almost 3 times higher 
for cells on the PHSRN than cells on the RGD (N=43 per each substrate). (C) Soluble 
PHSRN enhance also enhances cell migration rate and protrusions on RGD and cyclic RGD 
(cRGD) presenting SAM substrates (N=40 per each measurements). This establishes that 
the high migration rate and dynamicity of protrusions on the PHSRN-presenting surface are 
not the sole consequence of weak binding affinity of PHSRN but the interaction between 
PHSRN and cellular receptors. 
 
Soluble PHSRN Increase Migration Rate. In order to confirm that the high migration rate on 
PHSRN-presenting surface is not only because of weak affinity of PHSRN, soluble PHSRN 
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(Ac-PHSRN-NH2) was added to the culture medium (10 !M in 10 % bovine calf serum / 
DMEM) and cell migration rates were measured (Figure. 4C). Increased protrusion and 
migration rates were observed for cells cultured on all ligands (a mixture of RGD and 
PHSRN (PHSRN+RGD), RGD, and cyclic RGD (cRGD)) except PHSRN-only surfaces.  
 
Figure 2.5 SEM images were taken after critical temperature dried cells on PHSRN (left) or 
RGD (right). Cells were cultured for 10 hours on each substrate before proceeding to critical 
temperature drying. Peripheral and dorsal ruffling is observed form cells cultured on 
PHSRN-presenting surface while cells on RGD have smooth dorsal surface and trim 
periphery. 
 
cRGD is known to have a higher cell binding activity than the linear RGD by 1,000-fold due 
to its structural similarity to the natural RGD loop located in FIII10 of FN28,29. Furthermore, 
the live-cell imaging showed that soluble PHSRN changed rigid and spread cells to rounder 
forms, similar to the phenotype observed for cells on PHSRN-presenting surfaces. The 
treatment with soluble PHSRN increased long positive protrusions and lamellipodia 
stretching. However, when soluble NRSHP was treated to the cell culture media (10 !M), 
migration rate and protrusions did not noticeablely change, which emphasized the sequence 
specificity. Since soluble PHSRN can increase protrusion and migration rates on cRGD as 
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well as linear RGD in sequence specific manner, this suggests our observations of cells on 
PHSRN are caused by ligand effects rather than the weaker cell binding affinity of PHSRN 
relative to RGD. Prior reports that Ac-PHSRN-NH2 significantly increases invasion to 
extracellular matrices of sea urchin embryos of keratinocytes, fibroblasts and corneal 
epithelial cells seem to support our data17,30.  
 
Rufflings are Observed on PHSRN-Presenitng Surface. Cell morphology was further 
investigated by scanning electron microscopy (SEM) after performing critical point drying. 
As shown, cells on the RGD surface (Figure 5) have smooth and flat dorsal surface. The 
bundles of stress fibers are visible as the denser contrast areas. However, cells on PHSRN 
showed a rough and bulged dorsal surface with a clear distinction between cell body and 
lamellipodia, accompanying a significant amount of ruffling at the periphery as well as dorsal 
ruffling. This extensive peripheral and dorsal ruffling is a characteristic phenotype of cells 
with constitutively activated Rac GTPase. GTPases in eukaryote cells behave like molecular 
switches to control various biological processes such as adhesion, migration, polarization, 
proliferation, differentiation, and cell survival. In fibroblasts, Rho activation increases cell 
contractility, which leads to the formation of focal adhesions and actin stress fibers31,32. 
Whereas, Cdc42 and Rac activation leads to the formation of filopodia, lamellipodia, and 
membrane ruffles as well as focal contacts or complexes33-35.  
 
 
2.3.3 Upstream Regulator Rac1 and RhoA GTPases Are Responsible for the Different 
Observations  
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To confirm the observed difference in cellular behaviors on RGD and PHSRN surfaces were 
related to the activities of GTPases, pull-down assays were performed for cells subjected to  
 
 
Figure 2.6 Rac1 and RhoA pull-down assays are performed for the cells on different ligand 
presenting substrate. Cells were seeded and cultured 2 hours on the ligands presenting 
surface before proceeding to the pull-down assay. Cells (serum starved for 16 hours in 0.5% 
delipidated BSA/DMEM solution) were cultured in the presence (1% serum) or without 
serum (BSA) for 2 hours then proceeded for the assay. When serum stimulus exists, activity 
of Rac1 is higher for the cells on PHSRN presenting surface while activity of RhoA is higher 
for the cells on RGD presenting surfaces. These results are well matched to the previous 
results. 
 
each cell binding ligand with or without serum stimulus. Cells were incubated for 2 hours 
before proceeding with the activity assays to study sustained behaviors rather than an instant 
reaction to surface adhesion. Figure 6A shows the distinguished Rac1 activity changes with 
the presence of serum stimulation for the cells on RGD- and PHSRN- presenting surfaces. 
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The activity of Rac1 became higher for PHSRN surfaces and lower for RGD surfaces. 
Interestingly, Rac1 activity was more upregulated by adhesion to the RGD surface (without 
serum stimulus) compared to PHSRN surface, which was reversed when serum stimulation 
was added. These results suggest that the adhesion engagemnts to two different ligands 
provided diverse environmental contexts for serum-stimulated signaling, which converged at 
the GTPase level.  
 
 
2.3.4 A New Question  
 
Many researchers reported that the precise spatial positioning between RGD and 
PHSRN (30-40&) is a critical factor in the synergistic effect in cell adhesion and focal 
adhesion kinase(FAK) phosphorylation36. However, the two domains are not always ideally 
aligned for integrin receptor because of the flexible linker connecting them. The substratum 
FN binds influences its conformation. Its conformation affects many biological phenotypes 
such as focal adhesion assembly, cell adhesion, cell differentiation, gene expression, 
migration, and apoptosis37-46. The FN adhered to different surfaces varies cellular integrin 
specificity, which leads to these distinct biological consequences37,46. Even though it is 
unclear how exact changes in FN affect integrin specificities, Garcia et al showed that 
changes in orientation and distance of the flexible linkage between 9th and 10th type III 
domain of FN central cell binding domain may be the key factor effecting integrin 
specificities.  
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Furthermore, cells actively modify FN into the fibril form to obtain the full biological 
activity of FN. In the assembly of the FN fibril, cells contract to stretch FN and expose 
buried sites,48. In addition to revealing binding sites, stretching induced changes in the 
relative distance between them and straightened their hydrophilic loops49. By using steered 
molecular dynamics simulation, Krammer et al. predicted the stretching of FN unravels the 
connection between the synergy site and the RGD loop, which increases the distance and 
relative orientation between them by 20 & and 50° 50. Such functional decoupling of RGD 
and its synergy site may reduce "5#1 affinity because of the strict structural requirements36. 
Together with previous reports and the existence of invasin, a bacterial adhesion protein 
having 25-100 times more binding affinity than FN with no flexible linker within the integrin 
binding site 51, these results prompt a new question. Is the transient decoupling of the two 
domains containing RGD and PHSRN a relevant environmental que in cellular adhesion and 
migration? 
 
2.3.5 Modulation of the Observed Cellular Behaviors by Changing Compositions of 
Mixed Ligands on the Surface   
 
We further showed that cellular phenotypes could be modulated by the mixed 
presentation of PHSRN and RGD. It was found that the migration rate  
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Figure 2.7 Cell migration on the surface presenting RGD and PHSRN with different ratios 
on 1% HQ SAM (RGD+PHSRN) are evaluated. The migration rate increases, as the ratio of 
PHSRN increases on the mixed ligand presenting surface (filled square). Migration rate of 
cell could be modulated by controlling ratio of the presented ligands using HQ/TEG model 
system in easy and well-defined way. The corresponding change of surface concentration of 
RGD didn’t show any significant change for the cell migration rate (reversed triangle); 
implying that the change is caused by PHSRN, not by concentration change of major cell 
binding ligand RGD. 
 
increased with a higher ratio of PHSRN presented in mixed peptides (Fig. 7, filled square). 
Notably, migration rates were influenced by the mixed ligand effects of RGD and PHSRN 
rather than by the concentration change of RGD. The RGD concentration corresponding to 
its mixed ligand counterpart was mimicked by controlling HQ concentration of HQ/TEG 
yielding no noticeable changes in migration rate (Fig 7, reversed triangle). In detail, this 
mimcking of RGD ligand concentration on the mixed ligand surface was achieved by 
immersing gold substrates into the solution of HQ molecule (0.2, 0.4, 0.6, 0.8%) and TEG  
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Figure 2.8 Focal adhesion and actin fiber stain images for cells cultured 10 hours on SAM 
substrate presenting mixed RGD and PHSRN (Green : Paxillin, Red : actin, Blue : Nucleus; 
bar indicates 20µm). When PHSRN is dominant (right up), cells show rounder shape with 
cortical actin while cells show rigid shape with stress fibers on RGD dominant surface (right 
down). These results are well matches with cell migration rate evaluation data on mixed 
ligand presenting surface.   
 
molecule (99.8%, 99.6%, 99.4% and 99.2%) to prepare SAMs, followed by oxyamine 
tethered RGD immobilization as shown in figure 1. Correspondingly, figure 8 showed that 
cell morphology could be also modulated by the relative amount of presented ligands. When 
PHSRN was dominant (RGD:PHSRN = 2:8 and 4:6), more cells formed rounded shapes with 
a hollow center. On the other hand, when RGD was dominant (RGD:PHSRN = 6:4 and 8:2), 
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cells formed well-defined stress fiber bundles and dot like focal adhesions similar to a RGD-
presenting surface.  
 
 
2.4 CONCLUSION 
 
These results show how the facile control of ligand immobilziation can be applied to 
design a flexible and an unprecedent experimental setup. Combined with the bio-specificity 
of ligand presentations, this system will be valuable in deciding how the nature of adhesion 
(engagement of integrins to bio-ligands) will affect intracellular signal convergence, between 
cell adhesion and other extracellular signals like growth hormones. For example, the 
HQ/TEG system has already been applied to generate geometries, nano scale patterning, and 
ligand gradients, which are important charateristics of the ECM. These properties are not 
easy to mimick with current biological model systems (petri dish with protein adsorbed).  
The effect of adhesion conditions will add valuable pieces to the big puzzle of all adhesion-
mediated signaling pathways, such as MAPK cascade, focal adhesion complexes, and 
GTPases. It will be easier to solve this multivariable equation with ablilty to control each 
factor independently.  
In this report, we applied novel biological model substrate using the HQ/TEG system 
to present two functionally related ligands of FN; RGD and PHSRN. We showed that 
PHSRN, as previously reported16, can act as a weak cell binding ligand for 3T3 Fibroblasts. 
We further showed that the interaction of cells with PHSRN promoted cell migration, 
through increasing activity of Rac1, an upstream regulator for lamellipodia protrusion and 
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migration rate. We also showed evidence the adhesion to different ligands on SAMs provided 
specific context to cells, when they are stimuated by other extracellular signals (Figure 9). 
The funtional and structural coupling between two ligands in FN prompted a new question  
 
Figure 2.9 Decoupled RGD and PHSRN interact with cellular receptors to generate different 
phenotypes of cellular behaviors. Those consequences are caused, at least partially, from 
cellular interpretations for soluble factors under different adhesion context. The close 
functional and structural coupling of the two ligands liked by flexible linker prompts new 
question; if the tansient decoupling for two domains are relevant biological que for cellular 
decisions in vivo. 
 
concerning the transient decoupling of two domains of FN and subsequent PHSRN-receptor 
interaction. This process occurs in vivo owing to the flexible linker between two domains, 
and is a relevant biological que for cellular decision pertaining adhesion and migration. This 
facile and tight control of the adhesion environment is promising for studies for many other 
difficult questions; the quantitative assessment of the contributions from various extracellular 
stimui, cross-talk mechanism between adhesion and growth factor receptors, as well as the 
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reasons for retaining seemingly independent and redundant signalling pathways through 
evolution. We believe that HQ/TEG system will be a valuable addition to bolster the current 
biological model systems and provide a platform for further cell studies.  
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Chapter III 
 
 
 
 
 
 
 
AN INTERFACIAL OXIME REACTION TO IMMOBILIZE LIGANDS AND CELLS 
IN PATTERNS AND GRADIENTS TO PHOTOACTIVE SURFACES 
 
 
 
 
 
 
 
 
 
 
 64 
3.1 INTRODUCTION  
 
 In nature, cells exist in a highly evolving complex environment where numerous spatial 
input cues, such as gradients or patterns of ligands, are dynamically presented, which can 
then directly modulate a range of cellular behavior.1,2 In order to generate new in vitro model 
systems to study complex cell behavior, there has been tremendous interest in interfacing 
material science with cell biology. For fundamental cell biological investigations, self- 
assembled monolayers (SAMs) on gold have been the model system of choice for a variety 
of cell adhesion,3 migration,4 coculture,5 dynamics of intracellular protein activation,6 sub-
cellular nanoarchitecture formation,7,8 cell polarization,9 and cell patterning studies.10 There 
are several advantages of using SAMs on gold as a platform for preparing model systems to 
study cell phenomena over other materials: (1) SAMs are synthetically flexible (routine 
organic synthesis to generate almost any alkanethiol tethered molecule); (2) many surface 
spectroscopies to characterize interfacial reactions or associations are available (for example, 
surface plasmon resonance spectroscopy, atomic force microscopy, scanning tunneling 
microscopy); (3) mono- layers are electroactive (can modulate and/or characterize surface 
properties by electrochemistry); (4) for biointerfacial studies, SAMs can become inert to 
nonspecific protein adsorption (incorporation of ethylene glycol-terminated alkanethiols 
renders the surface inert); and (5) the method is compatible with cell culture conditions (pH 
7, 37 °C) and live-cell high resolution fluorescence microscopy.6 Taken together, these 
features allow for the generation of well-defined surfaces for biospecific interactions between 
ligands presented on the SAM and cell surface receptors. 
 To generate model surfaces to investigate complex biospecific cell phenomena, a 
synthetically simple method for immobilizing ligands in spatially controlled patterns and 
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gradients would lead to the design of more sophisticated model surfaces for interrogating cell 
behavior. Although several methodologies for biomolecule conjugation to SAMs on gold 
have been developed, including acid-base chemistry,11–13 Staudinger ligation,14–16 Click 
chemistry,17,18 Diels-Alder reaction,19 Michael addition,20 disulfide-thiol exchange reaction,21 
as well as other methods,22 only a few are ideal as an immobilization method to generate 
patterns, multiple ligand patterns, and gradients on SAMs for cell biological applications. To 
access biospecific dynamic cell behavior, the model surface must be able to change its 
properties by either releasing ligands or immobilizing ligands rapidly and in the presence of 
attached cells. 
 Herein, we report an interfacial oxime reaction as a conjugation strategy to immobilize 
ligands and cells in patterns and gradients to a surface. We characterize the reaction by 
electrochemistry and demonstrate the utility of this method by patterning multiple ligands 
and show it is amenable to generating surfaces for biospecific studies of cell adhesion and 
migration. We show that the reaction between surface-bound oxyamine groups and soluble 
carbonyl tethered groups is kinetically well behaved, fast, and generated in high yield under 
physiological conditions.23,24 Also, the reaction is chemoselective in the presence of cell 
lysates,23,24 and the resulting oxime is chemically stable for a range of pH’s and temperatures 
on a gold surface. From a synthetic perspective, the ketone moiety can also be easily 
incorporated into peptide ligands using solid-phase peptide synthesis.26 We further 
demonstrate that photochemical lithography can be applied to produce patterns and gradients 
at the microscale on the surface. 
 Nitroveratryloxycarbonyl (NVOC)-oxyamine surfaces are deprotected by UV 
illumination through a photolithographic mask to reveal oxyamine functional groups in 
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spatially controlled patterns. Ketone-GRGDS peptide is chemoselectively immobilized and 
shown to support biospecific ligand mediated cell adhesion. 
 
 
3.2 EXPERIMENTAL 
 
All amino acids were purchased from Anaspec, Inc. (La Jolla, CA). Rink amide MBHA resin 
was purchased from NovaBiochem. All reagents and solvents were purchased from Aldrich 
and used as received. THF was distilled from sodium benzophenone under nitrogen before 
use. All reagents used in cell culture were obtained from Gibco BRL. 
 
3.2.1 Synthesis 
 
2-(Undec-10-enyloxy)isoindoline-1,3-dione (1). A solution of N-hydroxyphthalimide (9.9 g, 
60.7 mmol) and sodium bicarbonate (4.95 g, 59 mmol) in DMF (100 mL) was heated to 80 
°C. After the mixture turned dark brown, bromoundecene (5.26 mL, 23 mmol) was added 
and the reaction mixture stirred for 10 h. The reaction mixture was extracted with water and 
ethyl acetate. The organic phase was concentrated and purified by column chroma- tography 
with 1:3 ethyl acetate/hexane to afford 7.1 g (97%) of product as a colorless oil: 1H NMR 
(CDCl3) ' 7.82 (m, 2H), 7.72 (m, 2H), 5.80 (m, 1H), 4.95 (m, 2 H), 4.17 (t, 2 H, J ) 6.8), 
2.03 (m, 2H), 1.77 (m, 2 H), 1.32 (m, 2 H), 1.19-1.27 (br s., 10 H). 
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Figure 3.1 Synthesis of NVOC-protected oxyamine terminated alkanedisulfide (7) 
 
Figure 3.2 Synthesis of ketone functionalized fluorescent dyes (9, 10) 
 
 
 68 
S-11-(1,3-Dioxoisoindolin-2-yloxy)undecyl Ethanethioate (2). A solution of 1 (2.0 g, 6.4 
mmol) and a catalytic amount of azobis(isobutylnitrile) in dry THF was heated under reflux. 
Upon observing N2 bubbles, thioacetic acid (0.91 mL, 12.7 mmol) was added to the reaction 
mixture and the mixture was kept stirring under reflux for 6 h. The reaction mixture was 
concentrated and separated by column chromatography with 1:3 ethyl acetate/hexane to 
afford 2.1 g (84%) of product as a white solid: 1H NMR (CDCl3) ' 7.82 (m, 2H), 7.72 (m, 
2H), 4.17 (t, 2H, J = 6.8), 2.84 (t, 2H, J = 6.8), 2.30 (s, 3H), 1.54 (brs, 4H), 1.34 (m, 2H) 1.28 
(brs, 12 H). 
 
S-11-(Aminooxy)undecyl Ethanethioate (3). To a solution of 2 (2.8g, 7.1mmol) in DCM (30 
mL) was added hydrazine (23 mL of 1.0 M solution in THF, 23 mmol) and the mixture was 
stirred at room temperature for 3 h. The reaction mixture was filtered and the filtrate was 
concentrated and then separated by column chroma- tography with 1:3 ethyl acetate/hexane 
to afford 1.7 g (91%) of product as colorless oil: 1H NMR (CDCl3) ' 3.65 (t, 2 H, J = 6.8), 
2.84 (t, 2H, J = 6.8), 2.30 (s, 3H), 1.54 (brs, 4H), 1.28 (brs, 14 H). 
 
11-(Aminooxy)undecane-1-thiol (4). To a solution of 3 (1.5 g, 5.7 mmol) in EtOH (22 mL) 
was added 12 N HCl (36 mmol, 3 mL) and the mixture was heated under reflux for 3 h. The 
reaction mixture was concentrated and dissolved in ethyl acetate. The organic phase was 
washed with a saturated aqueous solution of NaHCO3, water, brine, and sodium sulfate. The 
organic phase was concentrated to afford 1.0 g (79%) of a yellowish oil (4.5 mmol): 1H NMR 
(CDCl3) '3.65 (t, 2H, J = 6.8), 2.51 (q, 2H, J = 6.8), 1.54 (m, 4H), 1.28 (br s, 14H). 
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2-(Decyldisulfanyl)pyridine (5). A reaction mixture of decanethiol (1.0 g, 5.7 mmol), 
dipyridyl disulfide (1.9 g, 8.6 mmol), and dimethylaminopyridine (1.1 g, 8.7 mmol) in 
methylene chloride (30 mL) was stirred at room temperature for 8 h. The reaction mixture 
was concentrated and separated by column chromatography with 1:2 ethyl acetate/hexane to 
afford 1.5 g (92%) of product as a colorless oil (5.3 mmol): 1H NMR (CDCl3) ' 8.44 (d, 1 
H, J = 3.8 Hz), 7.72 (d, 1H, J = 3.8 Hz), 7.61(t, 1H, J = 2 Hz), 2.78 (t, 2H, J = 7.4 Hz), 1.64 
(m, 2H), 1.34 (m, 2H), 1.22 (m, 12H), 0.85 (t, 3H, J = 6.8 Hz). 
 
O-(11-(Decyldisulfanyl)undecyl)hydroxylamine (6). A reaction mixture of 4 (465 mg, 2.12 
mmol) and 5 (723 mg, 2.55 mmol) in 15 mL of chloroform was heated under reflux 
overnight. The reaction mixture was concentrated and separated by column chromatography 
with 1:3 ethyl acetate/hexane to afford 450 mg (55%) of white solid: 1HNMR (CDCl3) '3.65 
(t, 2H, J = 6.8 Hz), 2.65 (t, 4H, J = 7.2 Hz), 1.64 (m, 4H), 1.52 (m, 6H), 1.28 (brs, 24H), 0.86 
(t, 3H, J = 6.6 Hz). 
 
4,5-Dimethoxy-2-nitrobenzyl 11-(Decyldisulfanyl)undecyloxycar- bamate (7). A reaction 
mixture of 7 (150 mg, 0.38 mmol), dimethylaminopyridine (61 mg, 0.5mmol), and 4,5-
dimethoxy-2- nitrobenzyl chloroformate (140 mg, 0.50 mmol) in 10 mL of dry THF was 
stirred at room temperature for 12 h. The reaction mixture was then concentrated and 
separated by column chromatography with 1:2 ethyl acetate/hexane to afford 120 mg (87%) 
of product as white solid: 1H NMR (CDCl3) ' 7.70 (s, 1 H), 7.39 (s, 1 H), 7.01 (s, 1H), 5.57 
(s, 2H), 3.96 (s, 3H), 3.94(s, 3H), 3.88 (t,2H,J = 6.8Hz), 2.65 (t,4H, J = 7.2Hz),1.64 (m, 6H), 
1.24(28H), 0.86 (t, 3 H, J = 6.6 Hz); ESI mass in CH2Cl2 calcd 630.3, found 630.3. 
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Synthesis of Ketone-Terminated Fluorescent Dyes (9, 10). To a mixture of rhodamine 
sulfonyl chloride and triethylamine (1:3 mol equiv) in DMF (just enough to dissolve the two 
molecules), 1,4- dioxa-8-azaspiro[4.5]decane (1.2 mol equiv) was added and stirred at room 
temperature for 4 h. The product is then precipitated by ethyl ether. The dark purple 
precipitate is treated with HCl solution (15%) and stirred for 3 h at room temperature. 
Triethylamine was added until the solution reached pH 7. The reaction mixture was then 
concentrated to afford a dark purple powder (9): ESI mass in H2O calcd 639.2, found 639.1. 
The same procedure was used to synthesize a fluorescein-ketone dye molecule (10): ESI 
mass in H2O calcd 488.1, found 488.2. 
Molecule 11 was prepared as previously described.28,29 
 
Solid-Phase Peptide Synthesis of GRGDS-ketone (12). Ketone- functionalized GRGDS 
peptide was synthesized using a peptide synthesizer (CS Bio) at 0.1 mmol scale. 4-
Acetylbutylic acid was used without protection of the ketone group. The peptide was 
obtained from the resin after treating with 10 mL of TFA containing 5% water and 5% 
methylene chloride for 2 h under stirring and filtration. The filtrate was mixed with ethyl 
ether (40 mL) and the mixture was centrifuged at 3000 rpm for 15 min to obtain a white 
precipitate (2(). The precipitate was lyophilized overnight to obtain a white solid. ESI mass 
H2O calcd 714.4, found 714.3. 
 71 
 
Figure 3.3 Synthesis of an ethylene(glycol) incorporated oxyamine terminated 
alkanedisulfide (13) 
 
1-Bromo-7,10,13,16,19-pentaoxatriacont-29-ene (16). A solution of 15 (2.4 g, 6.9 mmol) in 
40 mL of dry THF was stirred in a ice bath for 30 min. NaH (1.34 g, 56 mmol) was then 
added to the solution and stirred at room temperature for 30 min. After further stirring in 
room temperature for 1 h, 1,6-dibromohexane (5.6 g, 23 mmol) in 5 mL of dry THF was 
added. The reaction mixture was stirred at room temperature overnight and the reaction 
mixture was concentrated in vacuo and separated by column chromatography with EA to 
afford 1.6 g (45%) of product that was a transparent oil: 1H NMR (CDCl3) ' 5.75 (m, 1 H), 
4.95 (m, 2 H), 3.5-3.7 (m, 18 H), 3.32-3.45 (m, 4 H), 2.0 (m, 2 H), ' 1.80-1.85 (m, 2 H), ' 
1.5-1.59 (m, 4 H), ' 1.2-1.45 (br s., 16 H). 
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2-(7,10,13,16,19-Pentaoxatriacont-29-enyloxy)isoindoline-1,3-di- one (17). A solution of N-
hydroxyphthalimide (1.08 g, 9.4 mmol) and sodium bicarbonate (789 mg, 9.5 mmol) in DMF 
(70 mL) was heated to 80 °C. After the mixture turned dark brown, 16 (1.6 g, 3.1 mmol) was 
added and the reaction mixture stirred for 10 h. The reaction mixture was extracted with 
water and ethyl acetate. The organic phase was concentrated and purified by column chroma- 
tography with 1:1:1 ethyl acetate/ethyl ether/ hexane to afford 1.3 g (45%) of product as a 
colorless oil: 1H NMR (CDCl3) ' (CDCl3) 7.82 (m,2H), 7.72 (m, 2H), 5.75 (m, 1H), 4.95 
(m, 2H), 4.18 (t, 2 H, J = 6.8 Hz), 3.5-3.7 (m, 16 H), 3.32-3.45 (m, 4 H), 2.0 (m, 2 H), 1.80-
1.85 (m, 2 H), 1.5-1.59 (m, 4 H), 1.2-1.45 (br, 16 H). 
 
S-11-(1,3-Dioxoisoindolin-2-yloxy)undecyl Ethanethioate (18). A solution of 17 (1.3 g, 2.2 
mmol) and a catalytic amount of azobis(isobutylnitrile) in dry THF was heated to reflux. 
After observing N2 bubbles, thioacetic acid (0.33 mL, 4.4 mmol) was added to the reaction 
mixture and the mixture was stirred under reflux for 6 h. The reaction mixture was 
concentrated and separated by column chromatography with 1:0.7:0.3 ethyl acetate/hexane/ 
ethyl ether to afford 400 mg (71%) of product as a pale yellow oil: 1HNMR(CDCl3) '7.82 
(m, 2H), 7.72 (m, 2H), 4.37 (t, 2H, J = 6.8 Hz), 3.84 (t, 2H, J = 2 Hz), 3.63 (t, 2H, J = 2Hz), 
3.50-3.62 (m, 14 H), 3.41 (t, 2 H, J = 2 Hz), 2.83 (t, 2 H, J = 6 Hz), 2.30 (s, 3 H), 1.80-1.85 
(m, 2 H), 1.5-1.59 (br, 6 H), 1.2-1.45 (br, 18 H). 
 
2-(29-Mercapto-7,10,13,16,19-pentaoxanonacosyloxy)isoindoline- 1,3-dione (19). To a 
solution of 18 (400 mg, 0.61 mmol) in EtOH (10 mL) was added 12 N HCl (12 mmol, 1 mL) 
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and the mixture was heated under reflux for 3 h. The reaction mixture was concentrated and 
dissolved in ethyl acetate. The organic phase was washed with a saturated aqueous solution 
of NaHCO3, water, brine, and sodium sulfate. The organic phase was concentrated to afford 
370 mg of product (!100%) as a transparent oil: 1H NMR (CDCl3) ' 7.82 (m, 2 H), 7.72 (m, 
2 H), ' 4.17 (t, 2 H, J = 6.8 Hz), 3.67 (t, 2 H, J ) 2 Hz), 3.50-3.62 (m, 16 H), 3.41 (t, 2 H, J = 
2 Hz), 2.5 (q, 2 H, J = 6 Hz), 1.80-1.85 (m, 2 H), 1.5-1.59 (br, 6 H), 1.2-1.45 (br, 18 H). 
 
2-(60-Hydroxy-7,10,13,16,19,42,45,48,51,54-decaoxa-30,31-dithi- ahexacontyloxy) 
isoindoline-1,3-dione (21). To a solution of 19 (370 mg, 0.60 mmol) in methylene chloride 
(20 mL) was added 20 (280 mg, 0.50 mmol). The reaction was stirred under reflux for 3 h. 
The reaction mixture was concentrated and separated by column chromatography with 1:1 
ethyl acetate/ethyl ether (5% MeOH) to afford 134 mg of product (25%) as a transparent oil: 
1H NMR (CDCl3) ' 7.82 (m, 2 H), 7.72 (m, 2 H), 4.17 (t, 2 H, J = 6.8 Hz), 3.67 (t, 2 H, J ) 2 
Hz), 3.50-3.65 (m, 32 H), 3.41 (t, 4 H, J = 2 Hz), 2.65 (t, 4 H, J = 6 Hz), 1.80-1.85 (m, 2 H), 
1.5-1.59 (m, 10 H), 1.2-1.45 (brs., 32 H).  
 
60-(Aminooxy)-7,10,13,16,19,42,45,48,51,54-decaoxa-30,31-dithi- ahexacontan-1-ol (13). 
To a solution of 21 (134 mg, 0.12 mmol) in DCM (10 mL) was added hydrazine (0.4 mL of a 
1.0 M solution in THF, 0.4 mmol) and the mixture stirred at room temperature for 3 h. The 
reaction mixture was filtered and the filtrate was concentrated followed by washing with a 
saturated NH4Cl aqueous solution. The reaction mixture was concentrated to afford 102 mg 
(90%) of product as a colorless oil: 1H NMR (CDCl3) 3.67 (t, 2 H, J ) 2 Hz), 3.50-3.65 
(m,34H),3.41(t,4H,J)2Hz),2.65(t,4H,J)6Hz),1.80-1.85 (m, 2 H), 1.5-1.59 (m, 10 H), 1.2-1.45 
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(br s., 32 H); ESI mass in CH2Cl2 calcd 873.6, found 873.6. 
 
3.2.2 Other Methods  
 
Preparation of Monolayers. The glass substrate (75 mm ( 25 mm) from Fisher was 
immersed into a piranha solution (1:1 volume ratio of H2SO4 and 31.6% hydrogen peroxide) 
for 4 h and cleaned thoroughly with deinoized water and absolute ethanol. Electron-beam 
deposition of Titanium (10 nm for electrochemical measurements and 3 nm for cell adhesion 
studies) and gold (100 nm for electrochemical measurements and 12 nm for cell patterning 
studies) on the glass substrate was performed consecutively. The prepared gold substrate was 
cut into 1.25 ( 1.5 cm2 and washed with absolute ethanol. All substrates were treated with a 
solution of the corresponding alkanethiols in absolute ethanol (1 mM) for 12 h and then 
rinsed with ethanol. 
 
Electrochemical Measurements. A Bioanalytical Systems CV- 100W potentiostat was used 
for all electrochemical measurements. HClO4 solution (1 M) was used as an electrolyte 
solution. A platinum wire was used as the counter electrode and Ag/AgCl was used as a 
reference electrode. All cyclic voltammograms were scanned at 100 mV/s. The substrates of 
SAM molecule 6 were immersed in the FcCHO solution (150 mM) and then transferred to 1 
M HClO4 solution in order to measure every 4 min. A SAM of 7 was immersed in a FcCHO 
solution (150 mM) after UV deprotection for 0 and 60 min. 
 
Photodeprotection of NVOC-oxyamine (7) Monolayers. The photodeprotection was 
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performed in a saturated semicarbazide solution to quench the aldehyde containing 
photobyproduct. The saturated solution was purged by N2 for 30 min before reaction. 
 
Cell Culture. Swiss Albino 3T3 cells (ATCC) were cultured in Dulbecco’s Modified Eagle 
Medium (Gibco) supplemented with 10% calf bovine serum and penicillin/streptomycin. The 
cells on the flask bottom were detached by treating with a solution of 0.05% trypsin/0.53 mM 
EDTA for 2 min in the incubator (37 °C in a humidified 5% CO2 atmosphere). Then serum-
free media was added and cells were precipitated by centrifugation at 1000 rpm for 10 min. 
The precipitate was resuspended in serum-free culture medium (!50,000 cells/mL) and 
added onto the substrates for 2 h. The substrate was then transferred to serum-containing 
media. 
 
 
3.3 RESULTS and DISCUSSIONS 
 
3.3.1 Interfacial Oxime Ligation after Photodeprotection: General Scheme and 
Characterizations  
                           
 The general scheme to photochemically unveil a reactive oxyamine surface in patterns 
and gradients and subsequent ketone tethered ligand immobilization is shown in Figure 3.5. 
A Photoprotected oxyamine alkanethiol (7) was synthesized and assembled on a gold surface 
(Figure 3.1). The photochemical protecting group NVOC effectively hides the oxyamine 
group from reacting with carbonyl-functionalized ligands. Upon UV illumination through a  
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Figure 3.4 Molecules appear in this chapter 
 
microfiche mask, the NVOC group is effectively removed to reveal the oxyamine group, 
which can subsequently chemoselectively react with carbonyl-functionalized ligands to 
generate an immobilized oxime linkage to the surface. 
 We first showed an oxyamine alkanethiol surface can react with carbonyl-bearing 
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ligands (Figure 3.6A) rapidly and in high yield. To characterize the real-time kinetics of the 
interfacial reaction, we immobilized a redox active ferrocenecarboxaldehyde [FcCHO (8)] to 
a surface containing a 1:1 mixture of oxyamine alkanethiol (6) and decanethiol. The extent  
 
 
Figure 3.5 Scheme describing a chemoselective interfacial oxime reaction to immobilize 
ligands to a photo-active surface. Illumination with ultraviolet light (365 nm) onto a NVOC-
oxyamine terminated SAM yields an oxyamine group which subsequently reacts with a 
ketone functionalized ligand forming a stable interfacial oxime linkage. 
 
and kinetics of the reaction were characterized by cyclic voltammetry. The surface initially 
has no redox peaks, but after the addition of FcCHO (150 mM, in ethanol), a peak at 348 mV 
steadily increased with reaction time, indicating that ferrocene is immobilized to the surface. 
Analysis of the rate of increase in peak currents of the ferrocene monolayer followed pseudo-
first-order kinetics, because the FcCHO was present in large excess relative to the 
immobilized oxyamine. The data was fit to an exponential decay (equation 3.1) to give a 
pseudo-first-order rate constant (k)) of 0.13 min-1, where It is the peak current at time t and 
Io is the initial peak current. 
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It = I0 (1 - exp-k’t) (equation 3.1) 
  
 This result shows that the oxyamine monolayer reacts chemoselectively with carbonyl 
containing ligands to give the corresponding oxime on the surface. To show the reaction 
went to completion, we compared the theoretical and calculated amount of ferrocene 
immobilized to a surface containing 50% oxyamine (a surface presenting molecule 6 should 
have 1:1 ratio of oxyamine to decanethiol, since it is a disulfide). After 60 min of reaction 
time, the redox peak for the ferrocene does not increase, indicating complete conversion of 
the surface from the oxyamine to the oxime conjugate. To determine the amount of 
ferrocene-oxime conjugate on the surface, we used the equation Q ) nFA*, where Q 
represents the charge and was calculated to be 6.38 µC, n represents the number of moles of 
electrons and is 1 for the redox interconversion of ferrocene and ferrocenium, A is the area of 
working electrode and was determined to be 1.3 cm2, and F is the Faraday constant and is 
96485 C/mol. The surface coverage (*) was determined to be 4.7 ( 1013 molecules/cm2 and 
is experimentally close to the theoretical coverage of a 50% surface of 5.0 ( 1013 
molecules/cm2. This result shows that the interfacial reaction is fast, kinetically well-
behaved, and can potentially tailor surfaces with a variety of carbonyl containing ligands. As 
controls, the redox peaks characterizing ferrocene are not observed when the substrate is first 
treated with a 10% aqueous acetone solution for 3 h (acetone will react with oxyamines to 
generate an oxime, effectively eliminating the oxyamine group from the surface) before the 
addition of the FcCHO solution. 
 
 79 
 
 
Figure 3.6 Cyclic voltammetry characterization of the kinetics of the interfacial oxime 
reaction and the photo-deprotection of NVOC-oxyamine SAMs. All cyclic voltammetry was 
performed in 1M HClO4 solution against Ag/AgCl reference electrode with scan rate of 
100mVsec-1. (A) A SAM of molecule 6 was immersed in a FcCHO (8) solution (150 mM) to 
determine the rate of interfacial oxime reaction. (inset) The plot of time versus normalized 
peak current (Ip) at 348mV was fit to an exponential decay and gave a pseudo-first order 
rate constant of 0.13 min-1. (B) A SAM of NVOC-oxamine (7) was immersed into a FcCHO 
solution (150 mM) after UV deprotection (365 nm) for 0 min and 60 min. After 60 minutes of 
illumination the FcCHO immobilized to the surface shows a cyclic voltammogram similar to a 
control substrate composed of molecule 6 showing no desorption or damage to the surface 
due to uv exposure.  The photo-deprotection was performed in a saturated semicarbazide 
solution to quench the aldehyde functional group of the photo-byproduct. 
 
 To generate molecularly controlled complex patterns and gradients on the surface, we 
synthesized a photoprotected oxyamine alkanethiol (7). By illuminating the surface with 
ultraviolet (UV) light of 365 nm through a patterned microfiche, we demonstrate spatial 
unveiling of the oxyamine group and subsequent immobilization of oxime ligands. We chose 
NVOC as the photoprotecting group because of the high efficiency of deprotection and UV 
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compatibility with SAM surfaces. However, upon UV illumination the photobyproduct of the 
NVOC- oxyamine bears an aldehyde functionality that immediately reacts with the oxyamine 
surface to essentially quench its subsequent reactivity. In order to eliminate the competing 
aldehyde pho- tobyproduct, the photodeprotection was performed in a saturated solution of 
semicarbazide (14) (in H2O and N2 purged for 30 min before usage), which acts as an 
efficient carbonyl scavenger. Under these conditions, UV irradiation of a SAM composed of 
molecule 7 revealed the oxyamine group for subsequent reactivity. The substrate was then 
immersed in FcCHO solution to show ligand immobilization. For complete 
photodeprotection, the surface was illuminated with UV light for 60 min and revealed 
approximately 95% of the oxyamine functional groups relative to a control substrate made of 
oxyamine disulfide (6) (Figure 3.6B). These results show the oxyamine can be revealed and 
immobilized with ligands with no deterioration in the surface or the oxyamine molecule. No 
immobilization was detected by cyclic voltammetry when the substrate was treated with a 
10% aqueous acetone solution for 1 h before introducing the FcCHO solution.  
 
3.3.2 Ligand Immobilization in Pattern and Gradient 
 
 To demonstrate that the methodology can immobilize ligands in a spatially controlled 
manner, we illuminated the photoprotected oxyamine surface with UV light through a 
patterned microfiche mask and added ketone-functionalized fluorescent dyes. Figure 3.7 
shows the general scheme of photopatterning and ligand immobilization. To introduce the 
ketone group to the fluorescent dyes (fluorescein isothiocyanate and sulforhodamine B acid 
chloride), we modified the structures by reacting with 1,4-dioxa- 8-azaspiro[4.5]decane, 
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followed by treatment with 15% HCl solution (Figure 3.2). To generate complex surface  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7 Scheme describing the spatial unveiling of oxyamine groups for ligand immobiliz
ation. A mixed monolayer of NVOC-protected oxyamine terminated SAMs is illuminated thro
ugh a patterned microfiche mask to reveal the oxyamine group for subsequent chemoselecti
ve immobilization of ketone-tethered ligands. 
 
patterns and multiple ligand immobilizations, we illuminated the surface through a 
microfiche patterned mask consecutively to pattern two different fluorescent dyes. The 
ketone-functionalized dyes 9 and 10are immobilized after each round of photodeprotection 
through a microfiche mask of pentagon and circle patterns, respectively. The fluorescence 
image shows that the dyes were immobilized onto only selected regions conforming to the 
photolithographic patterns (Figure 3.8) after two separate rounds of photodeprotection and 
immobilization. To create molecularly defined gradients on a surface that can immobilize a 
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variety of ligands, we extended the photodepro- tection and capture strategy.  
 
 
 
 
 
 
Figure 3.8 Fluorescent micrographs demonstrating multiple ligand immobilization in patterns 
to a surface.  Two consecutive rounds of photodeprotection with different photolithographic 
patterned masks followed by the immobilization of ketone tethered rhodamine (red (9)) (A) 
and fluorescein (green (10)) (B) fluorescent dyes, respectively. (C) A combined image of (A) 
and (B).  
  
 Figure 3.9A shows the fidelity of the microfiche gradient mask and the corresponding 
immobilization of fluorescent dye 9. Analysis of the fluorescent intensity profile along the 
axis of the dumbbell shape gradient surface shows that the relative fluorescence intensity 
closely corresponds with the gradient slope of the microfiche mask and confirms that the 
ligand is immobilized in a gradient on the surface. 
 
3.3.3 Cell Culture in Pattern 
 To demonstrate that this strategy is capable of immobilizing biologically relevant 
molecules and is compatible with cell culture conditions, we selectively immobilized the 
GRGDS peptide as a cell-binding ligand to an otherwise inert surface. The GRGDS peptide 
motif is found in the extracellular matrix protein fibronectin and is known to bind to cell 
surface integrin receptors to promote cell attachment, migration, and proliferation.25 A ketone 
functional group was introduced to the GRGDS peptide as a 4-acetylbutylic acid without any 
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protecting groups during routine solid-phase peptide synthesis (12).24 To show a biospecific 
interaction between the cells and the surface, SAMs consisting of a 2:98 ratio of molecules 
13 and 11 were generated and exposed to the ketone-peptide (12) for immobilization (10 
mM, in PBS, 2 h) (Figure 3.8). The major component of the surface consists of the ethylene  
 
 
Figure 3.9 Fluorescent micrographs and line profiles of molecularly defined gradients on the 
SAM surface.  (A) Microfiche film with patterned dumb-bell gradient (above) and the 
corresponding fluorescent image of the photo-deprotected and oxime immobilized ketone-
rhodamine (8) dye. (B) Intensity profile along the axis of the patterned surface showing a 
gradient fluorescent pattern. 
 
glycol group due to its ability to resist nonspecific protein adsorption and cell attachment, a 
critical requirement for biospecific studies of mechanistic cell adhesion and migration. 
Fibroblasts were then added, and after adhering to the surface, they migrated and proliferated 
to eventually become a lawn of cells that are contact inhibited. To show the interaction was 
due only to the peptide, addition of soluble GRGD peptide (without the ketone group, 10 µM, 
1 h) caused the cells to detach from the surface, indicating that the cells were adhered only 
via a ligand-receptor interaction. Furthermore, surfaces that were not exposed to the peptide, 
and therefore only present the oxyamine group and ethylene glycol groups, showed no cell 
attachment. 
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Figure 3.10 A phase contrast image of patterned attached cells on a SAM photo-
deprotected and immobilized with ketone-GRGDS.  The patterns are triangle, trapezoid and 
right triangle from the top row. The scale bar indicates 100!m. The micrograph was taken 3 
days after cell seeding. 
 
 To attach cells in patterns biospecifically, we prepared a mixed SAM of molecule 7 and 
tetra(ethylene glycol)-terminated alkanethiol (11) 2:98 and immobilized ketone-GRGDS (12) 
(10 mM in PBS, 2 h). Ultraviolet light illumination through a patterned microfiche mask 
followed by peptide immobilization and cell seeding shows cells patterned on the surface 
(Figure 3.10). To demonstrate that the cells were attached biospecifically via their integrin 
receptors to RGD-presenting surfaces, we showed that the addition of soluble RGD peptides 
(10 µM, 1 h) detached the cells from the surface. Furthermore, when a scrambled GRD- 
ketone peptide was immobilized, no cells attached to the surface. 
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3.4 CONCLUSION 
 
We have developed an interfacial oxime reaction that chemoselectively immobilizes 
ligands to photo-active surfaces in patterns and gradients.   We showed the sequential 
immobilization of two fluorescent dyes in patterns and also the immobilization of ligands in 
gradients.  The interfacial oxime reaction is fast, kinetically well-behaved, high yielding and 
can be characterized by electrochemistry.  Furthermore, we extend the strategy to immobilize 
peptide ligands (ketone-GRGDS) for biospecific cell attachment in patterns.   The strategy 
presented here can be used to immobilize a variety of ligands containing the ketone group 
and may be used for spatial and temporal control of ligands to generate dynamic surfaces to 
study cell behavior.  This methodology is compatible with attached cell culture and provides 
molecular level control of patterned ligands and gradients on surfaces.  This strategy can be 
extended to generate high-throughput arrays and in combination with high-resolution live-
cell microscopy can be used to investigate a variety of cell adhesion, cell signaling and cell 
migration phenomena.  
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4.1 INTRODUCTION 
 
 The ability to spatially and temporally control the attachment and detachment of 
molecules and cells on solid supports is important to research areas ranging from 
fundamental cell biology to biomaterial development and heterogeneous catalysis1–5. Various 
approaches have been developed to promote or inhibit cell attachment by altering the macro- 
scopic properties of the materials in situ, including mechan- ical stretching,[6–8] 
photochemical illumination,9–11 electro- chemical modulation,12,13 and thermal activation.14–16 
Alternatively, other strategies have focused on manipulating the cell–surface interactions at 
the molecular level by incorporating specific chemistries that can alter ligand presentation for 
attached cell culture through a noninvasive external switch. 17–23 To access more 
sophisticated and complex cell behavior studies, a surface strategy that can dynamically 
modulate attached cell culture at the molecular level catalytically, with spatial and temporal 
control in patterns and gradients, would greatly extend the utility of these model surfaces for 
a variety of cell motility, cell signaling, and cell–cell communication studies. These surfaces 
may also lead to the development of renewable surfaces for synthetic organic chemistry 
applications ranging from new solid-phase peptide synthesis resins to heterogeneous 
catalysis. 
 Herein, we report an electroactive quinone-terminated self-assembled monolayer 
(SAM) on gold that captures and subsequently releases ligands, proteins, and cells in situ 
through an electrochemical potential. We also show that the surface is catalytic for multiple 
rounds of immobilization and release that are pH dependent. From a synthetic organic 
chemistry perspective, a clean and quantitative functional- group transformation occurs from 
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an oxyamine group to a primary alcohol upon mild electrochemically applied potential. 
Furthermore, by extending this strategy with a photo- chemical approach, we demonstrate the 
immobilization and release of peptide ligands that mediate cell attachment in defined 
gradient patterns on inert surfaces. 
 
 
4.2 RESULTS and DISCUSSIONS 
 
4.2.1 Scheme of Electroactive Dynamic Surface 
 
Figure 4.1 Interfacial reaction between soluble oxyamine and quinone- terminated SAMs. 
Electrochemical oxidation [O] of the mixed mono- layers presenting hydroquinone and 
tetraethylene glycol groups converts the hydroquinone into the corresponding quinone. This 
quinone then reacts selectively with a soluble oxyamine-tagged ligand (R- ONH2) to give the 
redox-active oxime conjugate on the surface. The oxime is chemically stable and undergoes 
reversible redox coupling in HClO4 (1 m, pH 0). Electrochemical reduction [R] of the 
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monolayer in buffer solution at pH>0 spontaneously reverts the oxime to the hydroquinone 
by release of the surface-bound ligand as a hydroxy group. 
 
 Our approach is based on a redox-active hydroquinone- terminated SAM that can be 
electrochemically oxidized to the corresponding quinone (Figure 4.1). The resulting 
quinoneonolayer permits the selective coupling of soluble oxyamine ligands to the surface 
via an oxime conjugate. The oxime conjugate is chemically stable at pH 1–14, but upon 
applica- tion of an applied potential it can undergo a subsequent reversible redox reaction at 
low pH (1m HClO4, pH 0) with the ligand still covalently bound. However, electrochemical 
reduction of the monolayer at a higher pH value (phosphate- buffered saline (PBS), pH7) 
reverts the oxime to the hydroquinone and releases the ligand from the surface. The 
oxyamine terminal group on the ligand is converted to a hydroxy group and the surface is 
regenerated to the catalytic hydroquinone form for subsequent immobilization and release. 
                         
Figure 4.2 Surface groups used in this study. 
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 This strategy possesses several unique features that are important in the preparation of 
model substrates for modu- lating cell attachment. First, the immobilization and subse- quent 
release of ligands is controlled by mild electrochemical potentials under physiological 
conditions (PBS, pH 7), and therefore permits the modulation of ligands in the presence of 
attached cell culture.24,25 Second, the electroactive quinone and oxime monolayers permit 
quantitative characterization of the extent of ligand immobilization and release by cyclic 
voltam- metry (CV).26,27 Third, oxyamine moieties can be introduced into a variety of ligands 
through straightforward solution- and solid-phase synthesis to further extend the utility of 
these model substrates for other biological studies.28 A potentially wide range of soluble 
aminooxy-terminated ligands can be coupled to the quinone surface by the oximation 
reaction, and subsequently released from the surface electrochemically. Finally, the 
hydroquinone surface acts as a catalyst for the immobilization and release of ligands and also 
provides a route for a mild functional-group transformation of oxyamine groups to hydroxy 
groups. Because the surface is renewable, this approach greatly simplifies the preparation of 
monolayer substrates for both presenting biologically active ligands and dynamically 
modulating the activity of immobilized ligands. 
 
4.2.2 Characterization of Ligand Release  
 
 We first prepared monolayer surfaces presenting both hydroquinone (1) and 
tetraethylene glycol (2) groups (Figure 4.1), and characterized the interfacial immobilization 
and subsequent release of aminooxyacetic acid by CV. Figure 4.3 A shows the cyclic 
voltammograms of a mixed monolayer presenting both the hydroquinone and tetraethylene  
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Figure 4.3 Electrochemical characterization of the reaction between the quinone monolayer 
and soluble aminooxyacetic acid by CV. A) The hydroquinone-terminated monolayer 
undergoes electrochemical oxida- tion [O] at 539 and 600 mV and reduction [R] at 322 and 
95 mV in 1m HClO4 and PBS (pH 7.4), respectively. B) The quinone monolayer reacts with 
soluble aminooxyacetic acid to form the chemically stable oxime on the surface. The oxime 
undergoes reversible redox coupling at 624 and 484 mV in 1 m HClO4. C) Consecutive 
cyclic voltammo- grams of the oxime monolayer in PBS show the breakdown of the oxime, 
release of ligand, and formation of the hydroquinone in situ. D) The resulting hydroquinone 
is electrochemically oxidized to the quinone. Subsequent immobilization of the monolayer 
with soluble aminooxyacetic acid regenerates the oxime conjugate on the surface. All 
voltammograms were recorded at a scan rate of 50 mVs!1; the intersection of the 
crosshairs represents zero current. 
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glycol groups (1:1) in 1m HClO4 and PBS. The hydro- quinone undergoes a reversible two-
electron, two-proton process to give the corresponding quinone at different redox potentials 
in the two buffer solutions. Selective immobilization of soluble aminooxyacetic acid (0.2 M 
in H2O, 2 h) to the quinone monolayer resulted in the formation of a redox- active oxime on 
the surface. The changes in the redox-active peaks for the cyclic voltammogram in 1m 
HClO4 correspond to the oxidation and reduction of the oxime monolayer (Figure 4.3 B). 
The oxime is stable in 1 M HClO4 solution and can be cycled between the oxidized and 
reduced forms at least 50 times with no change in the voltammograms. 
 When the same electrochemical experiment was repeated in PBS, consecutive 
voltammograms showed a decrease in peak currents for the oxime monolayer, and an 
increase in peak currents corresponding to the hydroquinone–quinone redox couples (Figure 
4.3 C). This result suggests that the oxime undergoes electrochemical reduction to the 
corresponding hydroquinone by selectively releasing the ligand under physiological 
conditions (pH 7). To verify that the resulting peaks are characteristics of the oxidation of the 
hydroquinone and reduction of the quinone, we reimmobilized soluble aminooxyacetic acid 
(0.2 m in water, 2 h) on the monolayer. A cyclic voltammogram showed diagnostic peaks at 
624 and 484 mV in 1m HClO4, and confirmed the oxime conjugate on the surface (Figure 4.3 
D). 
 To determine the chemical nature of the ligand released from the surface, we 
synthesized a soluble oxime conjugate (3) by reacting benzoquinone with n-decanyl 
oxyamine. The oxime was chemically reduced in 1 M ascorbic acid. Characterization by 1H 
NMR and IR spectroscopy identified the released ligand as n-decanol. This result suggests 
that electrochemical reduction of the oxime monolayer in PBS regenerates the hydroquinone 
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by releasing the ligand as a hydroxy moiety. X-ray photoelectron spectroscopy of the surface 
after release shows no nitrogen present on the surface. We believe that nitrogen in the form 
of ammonia (NH3) is also released during the electrochemical reduction, but have not yet 
been able to identify this species. 
  
Figure 4.4 Normalized peak currents (Ip/Io) at 425 mV versus time for the consecutive cyclic 
voltammograms shown in Figure 4.3 (C). Inset: Plot of pseudo-first-order rate constants 
versus pH, which shows the relative rates of oxime degradation in various buffer solutions. 
 
 To further characterize the kinetics of oxime degradation in PBS, we examined the 
cyclic voltammograms obtained for the interfacial reaction. Figure 4.4 shows a plot of the 
normal- ized peak currents at 425 mV versus time for the data that correspond to the loss of 
oxime on the surface illustrated in Figure 4.3 C. The data were fitted to an exponential decay 
(equation 4.1) to give a pseudo-first-order rate constant of 0.01 s-1 in PBS, where It is the 
peak current at time t, I0 is the initial peak current, and If is the residual non-faradaic current. 
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                                         It = If + (I0 – If) exp(-k`t)  (equation 4.1) 
  
 We repeated the same electrochemical experiment in various buffer solutions to 
determine the effect of pH on the rate of oxime degradation and therefore release from the 
surface. Figure 4.4 (inset) shows a plot of the observed first- order rate constants (k’) versus 
pH. The data show a pH dependence on the rate of oxime degradation. Interestingly, the 
observed first-order rate constants increase from pH 0 to 3, and then decrease from pH 3 to 7. 
Although the reaction mechanism for the oxime degradation is complex and remains unclear, 
a break in the observed first-order rate constants at pH 3 suggests a change in the rate-
determining step at this buffer pH. Note that the oxime conjugate is stable in these pH ranges 
and only becomes unstable, and therefore releases, upon application of a reductive potential, 
thus enhancing its ability for dynamic surface applications. 
 To demonstrate the utility of this methodology for the release of biological ligands, we 
used the association of FLAG antibody to a monolayer presenting surface-immobilized 
FLAG peptides.29 We prepared a mixed monolayer presenting 1% hydroquinone group and 
99% tetra(ethylene glycol) groups. A high percentage of background tetra(ethylene glycol) 
density ensures that the monolayer surface completely resists nonspecific protein 
adsorption.30 The hydroquinone mono- layer was electrochemically oxidized at 750 mV for 
10 s in PBS to give the corresponding quinone. We next immobilized an aminooxy-
terminated FLAG peptide (4) onto the mono- layer (0.1 M solution in PBS, 4h). Association 
of FLAG antibody to the peptide-immobilized monolayer substrate was characterized by 
surface plasmon resonance (SPR) spectroscopy. 
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Figure 4.5 SPR spectroscopy demonstrating the association and release of anti-FLAG. A 
monolayer presenting surface-immobilized FLAG peptide through oxime conjugation before 
(top) and after (bottom) electrochemical (EChem) reduction, which releases the bound 
peptide. The 700 R.U. in anti-FLAG binding from the baseline before release of peptide 
shows biospecific association of the anti-FLAG. After release of the peptide no anti-FLAG is 
bound to the surface. 
 
 Figure 4.5 (top) shows the SPR sensorgram for the binding of anti-FLAG (0.1 mg mL-
1) onto the monolayer presenting immobilized FLAG peptides. When the peptide-
functionalized monolayer substrate was electrochemically reduced at 50 mV for 5 min in 
PBS causing release of peptide, a SPR sensorgram showed that the anti-FLAG did not bind 
to the surface (Figure 4.5, bottom). This result confirmed that electrochemical reduction of 
the monolayer released the immobilized FLAG peptide ligands from the surface through 
oxime degradation. 
 
4.2.3 Dynamic Co-culture Platform 
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 We next extended this methodology to cell biological applications by releasing peptide 
ligands that support cell adhesion in patterns on monolayer surfaces. To prepare surfaces that 
can capture and release patterned cells, we introduced a photochemical strategy that 
permitted the selective immobilization and release of ligands in defined patterns. Monolayers 
presenting nitroveratryloxycarbonyl (NVOC) hydroquinone groups undergo photochemical 
deprotection to reveal the hydroquinone in the selected region upon UV illumination through 
a photomask. This photochemical approach permits the patterning of a variety of soluble 
oxyamines onto the quinone monolayer.31,32 
 Figure 4.6 shows the photopatterning of attached cell culture on surface-immobilized 
RGD gradients, and subse- quent release of the patterned cells by an electrochemical 
potential.33 To demonstrate that electrochemical treatment of the monolayer is noncytotoxic 
to the attached cell culture, we used microcontact printing (mCp) to pattern hexadecane thiols 
that promote adhesion of another subset of cells through hydrophobic interactions on the 
same substrate.34 
 After the hexadecanethiols were printed in line patterns, the remaining bare gold region 
was backfilled with a mixed monolayer presenting 1 % NVOC-protected
 hydroquinone (5) and 99% tetra(ethylene glycol) groups. A photomask consisting of 
gradient patterns was placed in direct contact with the monolayer. Subsequent UV 
illumination of the monolayer through a photomask revealed the hydroquinone in select 
regions on the surface. The substrate was electro- chemically oxidized and then treated with 
soluble RGD oxyamine (0.1m, 4h) to form the corresponding peptide oxime conjugate on the 
surface. Swiss 3T3 fibroblasts were added to the resulting substrate and attached exclusively 
to both the microcontact-printed region (hydrophobic and therefore cell-adhesive) and the  
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Figure 4.6. Electrochemical release of photopatterned cells adhered to RGD gradient 
SAMs. A) Hexadecanethiols were microcontact printed to generate hydrophobic line 
patterns on the gold-coated glass substrate. B) The remaining bare gold region was 
backfilled with a mixed monolayer presenting both the NVOC hydroquinone and tetra- 
ethylene glycol groups. C) UV illumination through a photomask deprotected the NVOC 
groups to reveal the hydroquinone in select regions on the monolayer surface. D) The 
substrate was oxidized to convert the hydroquinone to the corresponding quinone. Addition 
of soluble RGD-oxyamine installs the peptide on the quinone monolayer through oxime 
formation. The resulting peptide oxime conjugate alters the inert photopattern area to 
biospecific cell adhesive. E) Addition of fibroblasts to the monolayer substrate resulted in 
cells adhering to both microcontact-printed and photopatterned regions. F) Mild 
electrochemical reduction of the gold substrate causes selective release of cells from only 
the RGD-defined gradient, whereas cells attached to the hydrophobic SAMs remain 
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adherent. G) Micrograph of a photo- mask with a gradient used in the preparation of the 
photopatterned RGD peptide ligands. H) Image showing patterned fibroblasts on a RGD 
gradient and on microcontact-printed line patterns. I) Electrochemical reduction of the 
monolayer leads to cell detachment on the gradient by release of the peptide ligand, while 
cells patterned on hydrophobic lines remain attached. 
 
photoactivated gradient region of the monolayer (presenting adhesive RGD peptides; Figure 
4.6 H). 
 To selectively release the surface-immobilized RGD ligands, a reductive potential of 
!50 mV was applied for 1 min in serum-free medium. Cells patterned on the gradient began 
to adopt a more rounded morphology and then detached from the surface. Figure 4.6 I shows 
a phase-contrast image of patterned cells after the electrochemical treatment. Cells on the 
gradient pattern were released, whereas cells on the microcontact-printed hydrophobic lines 
remained attached. This result confirmed that electrochemical reduc- tion of the monolayer 
released the RGD ligands in situ, and therefore caused the cells to detach from the otherwise 
inert surface as a result of a lack of surface-bound adhesive RGD ligands. We also showed 
the release of patterned cells on gradients overlapping with microcontact-printed 
hydrophobic regions, to demonstrate that this methodology can also be used for the spatial 
and temporal control of cell–cell interactions and co-cultures. 
 
 
4.3 CONCLUSIONS AND DISCUSSIONS 
 
 We have developed a general methodology to immobilize oxyamine ligands on an 
electroactive quinone monolayer, and subsequently release the same ligands from the surface 
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to regenerate the hydroquinone monolayer by electrochemical reduction. The redox activity 
between the quinone and oxime groups permits characterization of each step of the interfacial 
immobilization and release quantitatively by CV in real time. The hydroquinone surface is 
catalytic, can perform several rounds of immobilization and release of ligands, and also 
converts the oxyamine functional group to a hydroxy group by a mild electrochemical 
potential. This selective functional-group transformation may be used for applications 
ranging from solid-phase peptide synthesis and heterogeneous catalysis to chemical-based 
sensor amplification. Furthermore, we have extended this methodology to modulate the 
activity of immobilized peptide ligands to promote or inhibit the selective binding of protein. 
Finally, by combining this electrochemical strategy with a photochemical approach, we have 
demonstrated the immobilization and subsequent release of peptide ligands that mediate cell 
attachment in defined gradient patterns on inert surfaces. The examples demonstrated herein 
present a molecular level of control over ligand presentation for modulating cell behavior on 
model surfaces. We believe this methodology will provide a broad range of tailored 
substrates for new fundamental studies in attached cell culture and applications in synthetic 
chemistry and biotechnology.35-37 
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5.1 INTRODUCTION 
 
The ability to chemoselectively ligate a range of biomolecules, polymers, 
nanoparticles and nanomaterials is fundamental to current chemistry research and is crucial 
for a wide range of applications from protein conjugation, pharmaceutical therapies, 
molecular electronics, polymer synthesis and tissue engineering.1-4 The most used methods 
rely on ‘click chemistry’ type reactions that span Diels-Alder, Michael additions, thiol-ene 
reactions, Staudinger reactions, nucleophilic ring opening reactions, 1,3-dipolar 
cycloaddition, oxime/hydrozone formation reactions and native chemical ligations.5-18 
Although several conjugation methods exist and have been used for many applications the 
use of these methods for in vitro/in vivo biological studies and applications has been severely 
limited due to the special nature of the biological environment that limits the scope of 
reactions that may be employed.19-32 This sub-set of conjugation reactions for in vitro/in vivo 
studies and applications ideally, at physiological conditions, require kinetically well-behaved 
reactions that are fast, bioorthogonal, stable (covalent bonds), modular to conjugate a diverse 
range of molecules and non-cytotoxic.  Moreover, a conjugation strategy that can be: 1. 
Monitored and characterized with simple non-intrusive analytical methods, 2. Turned on or 
off for conjugation and 3.  Release molecules and be inexpensive would greatly complement 
and expand the scope of existing conjugation/release methods for a range of new 
applications.   
It is well known that oxyamine groups (R-ONH2) selectively react with carbonyl 
groups to form stable oxime products, which have been used as a popular bioconjugation 
methodology for the preparation of ligand microarrays and cell arrays33,34, therapeutics35,36, 
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fluorescent labeling37, combinatorial libraries38, artificial proteins39, glycoprotein mimetics40, 
chemically tunable polymer41, and biosensors.42 Oxime formation is chemoselective, fast, 
and stable in physiological condition.43,44 There are many types of oximes reported and 
characterized and each have unique characteristics including the quinone oxime; having an 
oxime moiety (R1R2C=N-O-R3) directly adjacent to the aromatic ring.45 Among them, the 
quinone oxime ether (QO) and ester have been studied in the field of stereo-electronic control 
in organic chemistry46, and applied to cytotoxin molecules47, therapeutics48, and photo-
induced iminyl radical generation.49  We have extensively studied and employed the quinone 
oxime ether (QO) as a quantitative immobilization strategy on gold and indium tin oxide 
(ITO) surfaces for a range of biotechnological and cell behavior studies.50-62 However, until 
now, the QO with its interesting aromatic structure and redox properties, has not been 
explored as a solution based conjugation strategy.   
The ability to cleave specific chemical linkages with mild stimuli is a powerful tool in 
designing small molecule drugs, in vivo biosensors,  solid phase synthesis as well as protein-
protein  interactions.63-68 There are several popular classes of cleavable linkers for these 
applications: cleavage by reduction (sulfhydryl and diazobenzene), oxidation (periodate), 
nucleophilic substitution, and base labile sulfones.69 Among them, reduction-induced 
cleavage is attractive due to its mild condition for cleavage at physiological conditions. For 
example, N-Succinimidyl 3-(2-pyridyldithio)propionate (SPDP) and 
Succinimidyloxycarbonyl-$-methyl-$-(2-pyridyldithio)toluene (SMPT) are often used for the 
preparation of immunotoxin conjugates that contain a monoclonal antibody which is cross-
linked to a protein toxin molecules; the antibody directed against tumor-associated antigens. 
Lambert et al. showed that a disulfide linkage between the antibody and toxin molecules 
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results in a potent toxicity when compared to non-cleavable linkages.70 Although the 
disulfide linkers have been successful in various fields where cleavable properties are 
required, there are always issues regarding disulfide exchange and premature cleavage at 
physiological conditions.  A major limitation of this method is that it is incompatible with 
cysteines due to their intrinsic lack of bio-orthogonality with disulfide bond formation.  
In this report, we develop a general strategy termed a chemoselective redox 
responsive ligation (CRRL) and release strategy for molecular conjugation and cleavage of a 
range of molecules in solution.  This strategy is based on the reaction of oxyamine tethered 
ligands with a redox controlled benzoquionone group for subsequent oxime formation and 
release.  This CRRL strategy is dynamic, kinetically well behaved, stable, bio-orthogonal, 
inexpensive, synthetically flexible and can be regenerated for subsequent rounds of 
conjugation and release at physiological conditions. Furthermore, the CRRL reactions can be 
monitored by simple UV-Vis spectroscopy methods and controlled by electrochemistry 
(either chemical redox reagents or applied potentials).  To our knowledge, the CRRL strategy 
is the only single method that is able to chemoselectively ligate molecules and to then release 
the molecules under redox control with regeneration for multiple subsequent rounds of 
conjugation and release.  
 
 
5.2 EXPERIMENTAL 
 
5.2.1 Synthesis and Purification of Peptide 
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All CRRL peptides were synthesized using an automated solid phase peptide 
synthesizer (CS Bio) with standard Fmoc SPPS methods at a 0.1 mmol scale. All amino acids 
were purchased from Anaspec. To ensure reaction completion, a 4-fold excess of Fmoc-
amino acids were used for each step of amino acid addition in the presence of HBTU and 
DIPEA in DMF. The SPPS resin (Fmoc-rink amide MBHA resin, Anaspec) was treated with 
a TFA solution containing 2.5 % water and 2.5 % triisopropylsilane for 1 h with bubbling 
nitrogen and filtered. The filtrate was mixed with cold ether to precipitate. The precipitate 
was washed with ether one additional time to completely remove TFA, and then extracted 
with water. The resulting CRRL peptides were purified by reverse-phase HPLC, using a 
Vydac C-18 semi-preparative column with a gradient of 0 - 100% organic solvent for over 50 
min (4 mL/min). The aqueous solvent was 95:5 water:acetonitrile with 0.1 % TFA while the 
organic solvent was 95:5 acetonitrile:water with 0.1 % TFA. The products eluted at 14.5 min 
for inter-CRRL RGD (6) and at 16.5 min for intra-CRRL RGD (9). The collected eluate was 
frozen and lyophilized to a white powder. 
 
5.2.2 Synthesis of HQAA (1) 
 
 
1,4-bis((tetrahydro-2H-pyran-2-yl)oxy)benzene (3) To a solution of hydroquinone 2 (4.6 g, 
42.2 mmol) in THF (40 mL), dihydropyran (16 mL, 206 mmol) and 3 drops of concentrated 
HCl were added. The reaction was stirred overnight at room temperature and then 
concentrated. The crude product was dissolved in a minimal amount of ethyl acetate and 
recrystallized in ethyl acetate/hexane affording 8.3g of white powder (71%). 1H NMR (400 
MHz, CDCl3): ' 1.54-1.65 (m, 6H), 1.80-1.84 (m, 4H), 1.96-1.97 (m, 2H), 3.56-3.59 (m, 
2H), 3.88-3.94 (m, 2H), 5.28 (t, 2H), 6.96 (s, 4H). 
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2,2'-((2-(6-bromohexyl)-1,4-phenylene)bis(oxy))bis(tetrahydro-2H-pyran) (4) To a solution 
of 3 (1.9 g, 6.8 mmol) in dry THF (Acroseal, Acros) in an ice bath, tert-butyl lithium (4.8 mL 
of 1.6 M, 7.68 mmol) was added dropwise over 5 min. This mixture was stirred for 15 min, 
followed by the addition of an excess of 1,6-dibromohexane (3.19 mL, 20.7 mmol); the 
reaction was then placed at room temperature. A white precipitate initially formed, however, 
after stirring for 12 h, the solution became clear yellow. The reaction mixture was diluted 
with 40 mL of methylene chloride and washed (1 x 20 mL of NH4Cl and 1 x 20mL of brine) 
and concentrated to a transparent oil. Flash chromatography was performed  (8:1:1 
hexane:ethyl acetate:methylene chloride), affording the product (1.94 g, 4.6 mmol, 68 %). 1H 
NMR (400 MHz, CDCl3): ' 1.62-2.02 (m, 20H), 2.66 (t, 2H), 3.38 (t, 2H), 3.58-3.62 (m, 2H), 
3.88-3.93 (m,2H), 5.27 (m, 2H), 6.82-6.84 (m, 2H), 6.97-6.70 (m, 1H). 
 
2,2'-((2-(6-azidohexyl)-1,4-phenylene)bis(oxy))bis(tetrahydro-2H-pyran) (5) To a solution of 
4 (2 g, 4.5 mmol) in DMF (30 mL), sodium azide (0.6 g, 9 mmol) was added. The reaction 
mixture was stirred for 2 h at 50 °C. The reaction was then extracted with water/methylene 
chloride and the organic phase was washed with water twice. The organic phase was 
concentrated to yield a clear oil with quantitative yield. 1H NMR (400 MHz, CDCl3): ' 1.32-
2.02 (m, 20H), 2.56 (t, 2H), 3.21 (t, 2H), 3.54-3.2.59 (m, 2H), 3.90 (t, 2H), 5.26 (m, 2H), 
6.80 (m, 2H), 6.94 (m, 1H). 
 
HQAA (1) To a solution of 5 (1.4 g, 3.4 mmol) and propargylglycine (0.6 g, 1.8mmol) in 70 
mL DMF, an aqueous solution (30 mL) of CuSO4#5H2O (750 mg, 3 mmol) and sodium 
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ascorbate (600 mg, 3 mmol) was added. The reaction mixture was stirred overnight at room 
temperature, concentrated in vacuo, and purified by flash chromatography (9:1 methylene 
chloride:methanol) to afford a clear oil (1.7 g, 2.3 mmol, 67 %). 1H NMR (400MHz, CDCl3): 
' 1.19-1.92 (m, 22H), 2.44 (t, 2H), 3.24 (t, 2H), 3.54 (t, 2H), 3.91 (t, 2H), 4.16 (t, 1H), 4.28-
4.47 (m, 3H), 5.27 (s, 2H), 6.71-6.96 (m, 3H), 7.28 (t, 2H), 7.37 (t, 2H), 7.58 (t, 2H), 7.69 (s, 
1H), 7.76 (d, 2H).    
 
5.2.3 Characterization 
 
Spectroscopy. Spectra were obtained using an Agilent Technologies model 8453 diode-array 
spectrophotometer for both standard and kinetics measurements. All the measurements were 
performed using quartz spectrophotometer cells (Aldrich chemical, 10mm, rectangular) in 
Dulbecco’s PBS (used as received) at room temperature. All measurements were initiated as 
immediately after sample preparation. 
 
Chromatography and Mass Spectroscopy. Analytical HPLC was performed on a Waters 
HPLC 1525 equipped with a 2998 diode array detector and an automated sampler. The 
samples were eluted through an Atlantis analytical column (C18, 5 !m, 6 x 150 mm) with a 
binary solvent system (Solvent A: optima grade water (Fisher) with 5 % optima grade 
acetonitrile (Fisher) and 0.1 % TFA; Solvent B: acetonitrile with 5 % water and 0.1 % TFA) 
with a gradient of 0 – 100 % solvent B over 50 min (1 mL/min).  For the LC-MS data for 
intra-CRRL RGD (6) and inter-CRRL RGD (9) peptides, samples were run on a Waters 
Acquity UPLC system coupled to a Waters Micromass ZQ Mass Spectrometer (Scanning 
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300-1600m/z) using a Waters Acquity UPLC column (BEH C18 1.7 !m, 2.1 x 150 mm, 30 
°C). The elution occurred in a gradient of binary solvents (Solvent A: optima grade water 
(Fisher) with 0.2 % formic acid (Fluka); Solvent B: Optima grade acetonitrile with 0.2 % 
formic acid), where solvent B increased from 1 % to 40 % over 20 min. 
 
5.3 RESULTS AND DISCUSSION 
 
5.3.1 Scheme of CRRL Conjugation and Release 
 
 
Figure 5.1 Cartoon scheme of the chemoselective redox responsive ligation (CRRL) and 
release strategy. A CRRL receptor tethered to a molecule 1 can be switched between the 
“off” state (full circle) and “on” state (incomplete circle) by mild chemical or electrochemical 
oxidation and reduction.  Only when the receptor is turned “on”, the CRRL ligand (red arrow) 
can react chemoselectively to form a conjugated molecule pair. The covalent ligation 
product is stable but can be selectively released by a mild chemical or electrochemical 
reductant. The CRRL cleavage reaction regenerates the receptor group while the ligand is 
irreversibly altered. Conjugation between the receptor and the ligand, as well as the 
cleavage reaction, are fast, mild, clean (no need for catalyst), bio-orthogonal, and 
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chemoselective in physiological conditions (pH of 7.4 and 37 °C) and complex protein 
mixture (cell lysates), which are essential characteristics for biological applications. 
 
Figure 5.1 shows a cartoon scheme of the dynamic CRRL strategy.  A CRRL receptor 
can be switched between the ‘off’ state and ‘on’ state by mild chemical or electrochemical 
redox changes. Only when the CRRL receptor is turned ‘on’ can it react chemoselectively 
with a CRRL ligand to generate a stable covalent conjugated pair.  The covalent ligation 
product is stable but can be selectively released by a mild chemical or electrochemical 
reductant.  The CRRL cleavage reaction regenerates the receptor group while the released 
ligand is irreversibly altered at the ligation site.  Subsequent rounds of conjugation and 
cleavage at physiological conditions (pH 7.4 and 37 oC) can be performed.  The reaction is 
bio-orthogonal, chemoselective and may be done in complex protein mixtures and cell 
culture.50,51 
Figure 5.2 shows the molecular structures of the solution based CRRL conjugation 
and release strategy. A hydroquinone (HQ) is the “off” CRRL receptor and can be converted 
to the benzoquinone (BQ) (“on” CRRL receptor) by mild chemical oxidants or 
electrochemical oxidation. This interconversion process is chemically and electrochemically 
reversible, which enables switching between the active and inactive forms for chemoselective 
conjugation. An oxyamine-tethered molecule (R-ONH2; the CRRL ligand) can conjugate 
selectively to the BQ form generating a covalent and stable quinone oxime ether (QO) as a 
ligation product. The QO can then be reduced by mild chemical reductants or 
electrochemical reduction to yield the aminophenol (AP) with release of the ligand as a 
hydroxyl-terminated molecule (R-OH). The HQ can then be regenerated from aminophenol 
(AP) by a subsequent mild redox process in low pH with the liberation of ammonia.71,72 
 114 
 
Figure 5.2 The molecular cycle of the CRRL conjugation and release strategy. A 
hydroquinone (HQ) is the “off” CRRL receptor and can be oxidatively converted to the 
benzoquinone (“on” CRRL receptor) form by mild chemical reagents or electrochemical 
methods. This interconversion process is chemically and electrochemically reversible, which 
enables switching between the active and inactive forms for chemoselective conjugation. An 
oxyamine-tethered molecule (R-ONH2; the CRRL ligand) can conjugate selectively to the 
BQ form generating a covalent and stable quinone oxime ether (QO) as a ligation product. 
The QO can then be reduced in mild conditions to yield the aminophenol (AP) with release 
of the ligand as a hydroxyl-terminated molecule (R-OH). The HQ can then be regenerated 
from AP by a subsequent mild redox process. 
 
5.3.2 Characterization of CRRL Conjugation and Release by UV-Vis Spectroscopy 
To monitor and characterize the kinetics of the stable intermediate products of the 
CRRL conjugation and cleavage strategy we used standard UV-Vis spectrometry. Upon 
oxidation of hydroquinone (HQ), benzoquinone (BQ) is formed, which can react with 
oxyamine groups (R-ONH2) to form the quinone oxime ether (QO).  The QO can then be  
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Figure 5.3 Monitoring the kinetics of CRRL conjugation between BQ (200 !M) and 
methoxyamine (100 mM) by UV-Vis spectrometry. (a) UV-Vis spectra showing the 
conversion from BQ (248 nm) to QO (320 nm) with a clear isosbestic point. (b) A plot of 
absorbance maxima versus time for BQ and QO. An exponential increase of QO and decay 
of BQ are fitted to pseudo first order kinetics to obtain k’ (4.2 x 10-3 s-1). (c) A plot of k’ 
versus varying [CH3-ONH2] to determine the second order rate constant k for the reaction of 
BQ with CH3-ONH2 to generate QO. The rate constant for CRRL conjugation is 3.4 x 10-2 M-
1s-1. 
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Figure 5.4 Determining the kinetics of CRRL cleavage of QO (200 !M) with dithiothreitol 
(DTT) (100 mM) by UV-Vis spectrometry. (a) UV-Vis spectra characterization for the 
cleavage reaction versus time (QO: 320 nm, AP: 292 nm). (b) A plot of QO (200 !M) 
absorbance (320 nm) versus time in the presence of the reductant DTT (100 mM) follows a 
pseudo 1st order exponential decay (k’ = 7.3 x 10-2 s-1).  (c) A plot of k’ versus varying [DTT] 
to determine the second order rate constant k for the cleavage of QO to generate AP. The 
CRRL cleavage rate constant k = 6.5 x 10-1 M-1s-1. 
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cleaved to generate the aminophenol (AP) with all species having diagnostic absorbances 
(HQ: 288 nm, $ = 2,520 M-1cm-1, BQ: 248 nm, $ = 20,300 M-1cm-1, QO: 320 nm, $ = 18,163 
M-1cm-1, AP: 297 nm, $ = 2,150 M-1cm-1).  Figure 5.3a shows the conjugation reaction 
between BQ and methoxyamine characterized by UV-Vis spectroscopy. To the solution of 
BQ (PBS, 200 !M), a solution of methoxyamine (PBS, 100 mM) was added immediately 
after the initial measurement (0 min). The visible isosbestic point demonstrates that BQ and 
QO are linearly related by stoichiometry, supporting that the reaction is quantitative. The 
absorbances at 248 nm and 320 nm were plotted against time in an exponential plot (Figure 
5.3b). The exponential graph was fitted to pseudo first order reaction kinetics in order to 
obtain k’. After solving for a series of k’s from different reaction conditions with excess 
methoxyamine, the k’ values can be plotted against [methoxyamine] (Figure 5.3c) to obtain 
the second order rate constant for CRRL conjugation, k = 3.41 x 10-2 M-1s-1 (PBS, room 
temperature).  
The same experiments and calculations were performed for the CRRL cleavage 
reaction. To a solution of QO (PBS, 200 !M), dithiothreitol (DTT) (PBS, 100 mM) was 
added (Fig 5.4a). Although DTT masks the spectrum that is lower than 260 nm, the decrease 
of QO absorbance at 320 nm and the appearance of AP at 292 nm could be observed. The 
absorbance peak is shifted from 297 nm to 292 nm for AP because of the high concentration 
of DTT.  For the case of reduction in low glutathione (GSH) concentration, AP has an 
absorbance peak at 297nm (Figure S2 in the Appendix A). Commercial AP (200 !M) in 100 
mM DTT and PBS also shows the same absorbance shift. The isosbestic point was not 
observed for the conversion of QO to AP because of the absorbance peak overlap.  The rate 
constant for the CRRL cleavage reaction was determined to be 6.5 x 10-1 M-1s-1 (Fig 5.4c). 
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The reaction products from both CRRL conjugation (QO) and cleavage reactions (AP) were 
characterized by NMR and mass spectrometry (Figure S1 in the Appendix A). These UV 
characterizations clearly show that the CRRL conjugation and cleavage reactions are fast and  
             
Figure 5.5 CRRL conjugation and cleavage reactions monitored and controlled by an 
electrode. A self-assembled monolayer of a HQ-tethered alkanethiol on a gold electrode has 
a characteristic cyclic voltammogram (top). The HQ can be electrochemically oxidized to BQ 
for CRRL ligation with oxyamine tethered ligands (R-ONH2), resulting in a shift of the 
diagnostic reduction peak associated with the redox species of QO (bottom cyclic 
voltammogram). The redox cycle of QO is stable at low pH (pH < 7) and does not cleave. 
When this redox cycle is performed at higher pH  (pH > 7), the oxime (QO) is efficiently 
cleaved to generate AP and then upon subsequent redox cycles to hydroquinone (HQ).  The 
regenerated HQ can then continue the cycle for subsequent rounds of conjugation and 
release of oxyamine tethered groups (R-ONH2). 
 
clean at pH 7.4.  We found that the key CRRL conjugation product (QO) is stable at room 
temperature in PBS for several weeks and could be stored indefinitely at 0 oC (Figure S3 in 
the Appendix A)  
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5.3.3 Characterization of CRRL Conjugation and Release by Cyclovoltammetry 
 
In order to demonstrate the CRRL conjugation and cleavage reactions could be 
monitored and controlled by electrochemical redox signals, we prepared self-assembled 
monolayers (SAMs) of HQ-tethered alkanethiols on a gold electrode.51 The HQ head group 
of the SAMs can be electrochemically oxidized and reduced (switched) between BQ and HQ 
repeatedly, without any loss of signal or side reactions. This HQ/BQ pair showed diagnostic 
potentials (Ox at 576 mV; Red at 230 mV) in the corresponding cyclic voltammograms (CV) 
(Figure 5.5, top). When an oxyamine-tethered ligand (R-ONH2) was introduced to the 
oxidized BQ SAMs, QO formation was accompanied by a shift of the diagnostic reduction 
peak (470 mV), displayed in the CV (Figure 5.5, below). Note that the CV not only conveys 
ligand immobilization by the peak shift, but also the extent of ligand immobilization by 
calculating the area of redox peaks (Q = nFA!; Q = charge, n = number of electron, F =  
Faraday’s constant, ! = surface coverage of the electroactive molecule). The QO formed 
after immobilization of oxyamine acetic acid was stable to an electrochemical redox cycle at 
pH 0 (1 M perchloric acid solution). However, after ligand conjugation, and upon increasing 
the pH the interfacial oxime ligand was rapidly released. After scanning the gold surfaces 
with CV, the original HQ/BQ redox signal was regenerated. These results clearly 
demonstrate that both mild chemical redox agents and electrochemistry (-200 mV to 800 
mV) can control CRRL conjugation and cleavage from a surface, which is attractive in 
designing new biotechnological microarray platforms or as a bioengineering tool for studying 
cell behavior.73 
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5.3.4 Characterization of CRRL Conjugation and Release by HPLC 
 
Figure 5.6 shows HPLC chromatograms for the characterization of the molecules and 
reactions involved in the CRRL strategy.  The CRRL reaction mixtures for conjugation and 
cleavage were stirred for 5 minutes in PBS and then characterized by HPLC. When HQ (200 
!M, 5.9 min) was mixed with methoxyamine (100 mM, 2.4 min), there was no formation of 
QO (Fig 6a). However, the BQ (200 !M) formed QO instantly with methoxyamine, which 
resulted in a shift of the BQ peak (7.9 min) to the newly formed QO (16.7 min) (Fig 6c). 
Figure 5.6d shows that AP is exclusively eluted from a CRRL cleavage reaction; AP elutes 
earlier than HQ (4.5 min). The HPLC chromatograms at 214 nm for each reaction showed 
that CRRL conjugation and cleavage reactions are exceptionally clean and fast at pH 7.4 
(PBS, room temperature). All of the peaks were separated and characterized by NMR and 
mass spectrometry (Figure S1 in the Appendix A). The ability to switch between HQ and 
BQ, as well as the orthogonality of the reaction between BQ and oxyamines, is crucial for 
designing smart molecules that contain both  a CRRL receptor and a CRRL ligand. As long 
as the CRRL receptor is in the off state (HQ), it cannot react with the oxyamine moiety until 
the molecule encounters an oxidative environment (as shown for intramolecular and 
intermolecular CRRL peptides below), enabling temporal and/or spatial control of molecular 
conjugation and release.  This dynamic behavior can also be applied to intermolecular CRRL 
conjugation, in that the ligation only occurs when oxidative conditions exist in the reaction 
mixture. It should be noted that the initiation cue for the CRRL strategy is not a catalyst, but 
an oxidative environment. 
 121 
                        
Figure 5.6 HPLC chromatograms for the molecules and reactions involved in the CRRL 
strategy. (a) Reaction between HQ and methoxyamine. There is no formation of the 
conjugate QO when the CRRL receptor (HQ) is in the “off” state. (b) HPLC chromatogram of 
BQ formed by the oxidation of HQ via chemical or electrochemical methods. (c) Reaction 
between BQ and methoxyamine quantitatively yields the QO product. (d) The CRRL 
cleavage reaction in reductive conditions converts the QO to AP quantitatively. All the 
reactions were in PBS (pH 7.4) at 25 oC.  
 
5.3.5 Proof-of-Concept Peptide: Intra-CRRL RGD and Inter-CRRL RGD 
 
To conjugate a range of biomolecules using the CRRL strategy, we used standard 
solid phase peptide synthesis (SPPS) to generate peptides containing the hydroquinone group  
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Figure 5.7. (a) Synthesis of a protected hydroquinone tethered Fmoc amino acid (HQAA; 1) 
for use in solid phase peptide synthesis to generate peptides containing the hydroquinone 
group for site specific CRRL chemistry. (b) Scheme showing how HQAA (1) can be added to 
any site within a peptide by applying standard solid phase peptide synthesis technology. 
This strategy allows for the CRRL method to be incorporated into a variety of biomolecules.   
 
at various locations.  We first synthesized a protected hydroquinone tethered Fmoc amino 
acid (HQAA; 1) that could easily be incorporated into a standard solid phase peptide 
synthesizer for site-specific CRRL chemistry (Figure 5.7a).  A Tetrahydro-2H-pyran (THP) 
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protected HQ-tethered alkyl azide (5) was synthesized and conjugated to an Fmoc-protected 
propargyl glycine by 1,3-dipolar cycloaddition.  The HQAA (1) can be incorporated into any 
position in a peptide sequence, enabling control of the conjugation site with routine Fmoc 
SPPS (Figure 5.7b). The THP group can then be deprotected yielding the HQ using the 
standard trifluoroacetic acid (TFA) cleavage step for peptide release from a resin.  CRRL’s 
compatibility with facile SPPS is an important feature for generating a range of biomolecules 
including carbohydrates, polymers, nucleic acids, proteins and small molecule ligands and 
nanomaterials that contain the hydroquinone group for a broad range of applications in 
material science and biology.  
In order to demonstrate the utility of the CRRL strategy we used the well-known cell 
adhesion peptides discovered by Pierschbather and Ruoslahti as a model system.  They 
reported the short peptide sequence Gly-Arg-Gly-Asp-Ser (GRGDS) found in the 
extracellular matrix protein fibronectin to be a minimum cell adhesion ligand for integrin 
receptors on cell surfaces.74 Although GRGDS alone can result in cell adhesion, several other 
peptide sequences including PHSRN (found in fibronectin within the FIII9 domain) have 
been shown to have a synergistic adhesion effect.75 Furthermore, it has been shown that 
cyclic-RGD has a higher activity towards cell binding than linear-RGD (Kd of nM versus 
!M, respectively) due to the structural similarity between the cyclic form and the natural 
RGD loop in the FIII10 domain.76 We chose to focus on the RGD cell adhesive peptide to 
demonstrate the generation of a dynamic biomolecule using CRRL, which can modulate its 
biological activity by inducing structural changes upon sensing different redox environments.  
Two proof-of-concept peptides, intra-CRRL RGD (6) and inter-CRRL RGD (9), were 
synthesized to demonstrate the utility of the CRRL methodology.  
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The intra-CRRL RGD peptide (6) has the HQAA (1) at the C terminus and an 
oxyamine group at the N terminus (Figure 5.8a).  An added feature of the CRRL strategy is 
the ease of incorporation of an oxyamine group into a peptide by using a commercially 
available boc-protected oxyamine acetic acid during standard solid phase peptide synthesis.  
In a reducing environment (1mM DTT in PBS), the intra-CRRL RGD (6) remains in the 
linear form for more than 4 days (PBS, 25 oC). When the molecule encounters oxidative 
conditions (10 equivalents of copper (II) sulfate pentahydrate in PBS), the HQ is immediately 
oxidized to the BQ form, which reacts rapidly with the oxyamine-functionalized N terminus 
to generate a cyclized RGD peptide (7) (Figure 5.8b). The cyclized intra-CRRL RGD peptide 
(7) is stable for weeks in PBS and room temperature (25 oC). To regenerate the linearized 
RGD peptide, the addition of a chemical (100 mM DTT in PBS) results in the cleavage of the 
oxime bond to generate the AP group and a hydroxyl-functionalized N terminus (8) (Figure 
5.8c). As this intra CRRL peptide has both a CRRL receptor and a ligand, characterization of 
each state of the peptide by UV-Vis spectroscopy is possible because of the diagnostic 
signature absorbances of each electroactive group (HQ, BQ, QO, AP).  This allows for facile 
monitoring of the chemical changes occurring during the CRRL cyclization and cleavage 
steps.  As added evidence, mass spectrometry characterization of each reaction product 
confirms that each transformation is essentially quantitative and proves the existence of the 
HQ, oxyamine, QO, AP, and the corresponding hydroxyl terminated group in a single 
peptide during the course of the CRRL conjugation and release steps.  
Similarly, inter-CRRL formation and cleavage between RGD and PHSRN was 
characterized by mass spectroscopy. The inter-CRRL RGD peptide (9) (Figure 5.9a) has a 
HQAA at the N-terminus for the conjugation of an oxyamine-tethered PREDRVPHSRN  
 125 
                    
Figure 5.8 Intramolecular CRRL. A peptide (intra-CRRL RGD, (6)) containing the HQAA (1) 
and a terminal oxyamine group was synthesized using standard solid phase peptide 
synthesis. The CRRL strategy was used to generate a cyclic peptide characterized by liquid 
chromatography and mass spectrometry. (a) Structure of the intra-CRRL RGD (6) peptide. 
(b) A mild oxidant Cu2+ was added in order to oxidize the HQ to BQ followed by rapid 
intramolecular oxime formation to generate a cyclic peptide (7). (c) A mild reductant DTT 
was added to the solution of cyclized RGD peptide (7) to reduce and therefore cleave the 
oxime bond to generate the linear peptide (8). Mass spectrometry characterization of each 
product in the intramolecular CRRL strategy were shown.  All the reactions were performed 
at physiological conditions (PBS, pH=7.4, 37.0 °C). 
 
 126 
                           
Figure 5.9 Intermolecular CRRL demonstrating the conjugation of two different peptides. 
One peptide (inter-CRRL RGD (9)) contains the HQ group while the other 
(PREDRVPHSRN) has an oxyamine group.  Each are easily synthesized using standard 
solid phase peptide technology. (a) Inter-CRRL RGD (9) peptide in PBS before reaction. (b) 
A mild oxidant Cu2+ and oxyamine-PREDRVPHSRN were added to the PBS solution of 
inter-CRRL RGD (9) peptide to enable rapid intermolecular CRRL conjugation of the two 
peptides (10) (PBS, 37.0 °C). (c) The CRRL product peptide (10) was then selectively 
cleaved upon treatment of the reductant DTT to yield the linear RGD peptide (11). (Bottom) 
Mass spectrometry characterization of each product in the intermolecular CRRL strategy.  
All the reactions were performed at physiological conditions (PBS, pH=7.4, 37.0 °C). 
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peptide. Oxidative conditions yielded the large hybrid peptide (10) having a molecular mass 
of 2479.25 (Figure 5.9b), which can then be dissociated by DTT; yielding the corresponding 
AP-RGD (11).  We have a program to study cell adhesion, polarization and migration and 
future studies will aim to use these peptides in cell adhesion and motility studies.77-79 
                            
Figure 5.10 The intra-CRRL RGD peptides were also characterized by selected ion 
chromatography. Structures with a cartoon representation of each of the intramolecular 
peptide CRRL species. Each peak represents a specific mass number that corresponds to 
each peptide species undergoing the CRRL and release. (a) Linear intra-CRRL RGD (6) 
peptide in PBS. (b) The RGD peptide (6) is cyclized (7) in an oxidative environment. The 
multiple peaks are related to isomers of QO conjugation. (c) Linear form of RGD (8) is 
generated by reduction.  
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As further characterization, a selected ion chromatogram was presented to 
demonstrate that each intra-CRRL peptide species behaves similarly to the corresponding 
parent molecule without the peptide (Figure 5.6), in terms of the elution durations from a 
C18 column (Figure 5.10). UV-Vis spectroscopy confirmed that the HQ-peptides (9) behave 
similarly to the parent molecules (Figure 5.11). The reduced form of the inter-CRRL RGD 
(HQ-peptide (9)) was dissolved in H2O and oxidized by the addition of 10 equivalents of 
Cu2+ to generate the oxidized BQ-peptide. When methoxyamine (100 mM, ddH2O) was 
added, oxime formation occurred instantly (QO-peptide). The QO-peptide was converted to 
the AP-peptide by treatment with DTT (100 mM).  The HQ can be regenerated by a redox 
process on AP at low pH with release of ammonia.71,72 All of the UV spectra for the various 
CRRL peptides correspond to those of HQ, BQ, QO and AP (Figure 5.3, 5.4).  Taken 
together, these results show the CRRL strategy can be used to cyclize molecules, conjugate 
to other molecules and release molecules responding to environmental redox stimuli with 
real-time characterization by a non-invasive straightforward UV-Vis absorption spectroscopy 
technique. This facile characterization is not only important for identifying species but for 
also determining actual amounts of the CRRL species and for monitoring the kinetics and 
therefore degree of conjugation. 
The CRRL strategy is a new class of conjugation chemistry in that it allows 
chemoselective conjugation and cleavage that is responsive to specific redox stimuli. The 
protected HQ can be incorporated into routine solid phase peptide synthesis as a HQAA (1).  
This allows for precise control of the site for chemoselective conjugation to other molecules 
or for intramolecular cyclization. For the cleavage reaction, the released molecule undergoes 
a functional group transformation, converting the oxyamine moiety to a hydroxyl group. 
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CRRL can therefore also be used in protecting functionally important hydroxyl groups, 
which can be critical in the synthesis of carbohydrates or prodrugs.  
 
      
Figure 5.11 The different stages of the CRRL and release strategy can be monitored by UV-
Vis absorbance spectroscopy.  For example, the inter-CRRL RGD (9) peptide (HQ-peptide) 
undergoing the CRRL process contains a distinct electroactive group with a corresponding 
diagnostic absorbance spectra. HQ-peptide was oxidized with Cu2+ to yield BQ-peptide 
(ddH2O, RT). When methoxyamine (100 mM) was added to the solution, a QO-peptide (10) 
formed, which can be cleaved by mild reduction to produce the AP-peptide. UV absorbance 
of each peptide species (HQ: 288 nm, BQ: 248 nm, QO: 320 nm, AP: 292 nm). 
 
The chemical conversion of QO to AP is also important for the industrial production 
of AP, which is the major chemical intermediate of acetaminophen and other drugs and is 
also critical for the photography industry. The most popular synthesis for AP involves the 
metal catalyzed reduction of nitrophenol in harsh (high temperature and pressure) conditions. 
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However, this method produces excessive environmental pollution and wastewater, as well 
as residual catalyst. Since the CRRL cleavage occurs at mild physiological conditions with 
no waste other than an alcohol and with no use of a metal catalyst, it may be able to improve 
industrial production of AP and/or drug production.  
Additionally, QO offers an alternative to disulfide bonds as a cleavable linker when 
cysteine groups are present on any of the two target biomolecules. We determined that CRRL 
cleavage takes 10 hr for reaction completion in the presence of 5 mM glutathione (GSH) in 
PBS (Figure S2 in Appendix A). The facile electrochemical CRRL reaction on conductive 
surface may also be applied to industry applications, such as affinity chromatography 
(protein concentration) or dynamic solid phase organic synthesis or renewable microarrays.  
 
 
5.4 CONCLUSIONS 
 
In summary, we introduce a new chemoselective redox responsive ligation and 
release strategy.  This strategy is based on the ability of a hydroquinone to oxidize to a 
benzoquinone for subsequent reaction with oxyamine tethered ligands to generate a stable 
oxime product.  The oxime can then undergo an irreversible cleavage upon a reductive 
environment to generate an aminophenol and a primary hydroxyl terminated ligand.  The 
aminophenol is stable and can be brought back to the original hydroquionone with mild 
redox chemistry for subsequent rounds of conjugation and release.  The CRRL strategy can 
be monitored in real-time by standard UV-Vis absorption spectroscopy and modulated by 
chemical or electrochemical methods.  A non-natural amino acid containing the 
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hydroquinone group was synthesized and shown to incorporate at selective positions within a 
peptide by using standard solid phase peptide synthesis.  As a demonstration, an 
intermolecular and intramolecular CRRL strategy was used to generate dynamic cyclic 
peptides and two tethered peptides that could be conjugated and cleaved.  The CRRL 
methodology not only shares all the advantages of traditional oxime chemistry (fast, 
quantitative and chemoselective), but also has a dynamic attribute associated with 
conjugation and cleavability. CRRL conjugation and cleavage occurs fast and quantitatively 
in physiological conditions without the need for a catalyst. Furthermore, the CRRL strategy 
is synthetically flexible and can also be used with hydrazine type molecules instead of 
oxyamines to generate conjugated hydrazones.80 We believe that CRRL is a general 
methodology for conjugation and release and will be a useful tool for scientists and engineers 
in various fields aiming to design smart molecules and materials, which either alter their 
biological activities according to specific changes in their physiological environments or for 
material science applications.81,82 The CRRL strategy is inexpensive, bioorthogonal, 
dynamic, kinetically well behaved, synthetically modular and straightforward to monitor and 
control.  Preliminary evidence shows that the QO may be cleaved with strong ultraviolet light 
for potential photo-induced cleavage applications. To our knowledge, the CRRL strategy is 
the only single method that is able to chemoselectively ligate molecules and to then release 
the molecules under redox control with regeneration for multiple subsequent rounds of 
conjugation and release. Future research will explore how the CRRL strategy may be used to 
release or conjugate molecules to generate dynamic polymers, carbohydrates and mixed 
CRRL bio-molecules (peptides, nucleic acid, lipids) in vivo.83-87 We believe, the ease of the 
CRRL strategy should find wide use in a range of applications in biology, tissue engineering, 
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nanoscience and material science and will significantly add to the suite of current 
conjugation and release strategies.  
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6.1 CONCLUSIONS AND FUTURE DIRECTIONS 
 
 
This dissertation focused on the development of a novel engineered biological model 
system based on self-assembled monolayers. Bio-specific interactions between ligand and 
cell adhesion receptors as well as facile control over cell adhesion conditions were major 
advantages over current model systems. They helped provide deeper insight of adhesion 
mediated signaling as well as cross talk with other receptors. For example, HQ/TEG system 
was applied to study adhesion effects of two structurally and functionally coupled ligands, 
RGD and PHSRN, on 3T3 swiss albino fibroblasts in chapter 2. The observed difference in 
cellular behaviors was caused by corresponding differences in activities of Rac1 and RhoA. 
Furthermore, cross-talk was observed between integrins and growth factor receptors on 
PHSRN-presenting surface, but not RGD-presenting surfaces. In this chapter, cells behaved 
very differently on both ligands; migrating faster with dynamic lamellipodia protrusions on 
the PHSRN-presenting surface while stationary with well developed adhesion structures and 
stress fibers on the RGD-presenting surface.  
Consideration of these dramatically different adhesion effects in the context of close 
coupling of these ligands prompted a new question; is the transient decoupling of two 
domains a relevant biological question in vivo? The question is further supported by several 
reports of FN stretching by endogenous cellular tension inducing decoupling and adsorption 
onto the substratum. This process potentially changes the distance and orientation between 
the two domains containing RGD and PHSRN as well as their engaged receptors. The 
question only can be answered by developing non-invasive, real-time monitoring and control 
over the distance and orientation of 9th FNIII and 10th FNIII domains of FN. Since the 
distance between two domains (~40Å) is in the applicable range of fluorescence resonance 
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energy transfer (FRET) microscopy (10~100 Å), FRET donor and acceptor incorporation 
onto the two domains of FN seems to be promising approach. The real-time change of 
distance and orientation of FN by endogenous tension of cell will be correlated to the 
changes in cellular behaviors in terms of orientation, contraction, actin rearrangement, focal 
adhesion turn over, and lamellipodia protrusions. 
Chapter 3 focused on the development of a novel methodology to immobilize ligands 
with spatial control by applying a photolithographic strategy. The NVOC-protected 
oxyamine was revealed only when UV light was impinged through photomask to selectively 
reveal an oxyamine group. The revealed oxyamine group formed oxime ligations with 
ketone- functionalized bioligands. The mixed SAMs with TEG enabled immobilization of 
multiple ligands in various shapes, enabling cell culture in specific geometries as well as 
gradients. 
Chapter 4 introduced dynamic control over quinone oxime conjugation and release on 
a conductive surface in physiological conditions. First, the hydroquinone is oxidized to the 
benzoquinone form, which reveals a ketone for oxyamine conjugation. The resulting quinone 
oxime ether is stable for the electrochemical reduction in pH 0 (1M perchloric acid soln.). 
Interestingly, the quinone oxime conjugation is cleaved by reduction in higher pH buffer. 
The conjugation and cleavage was confirmed by cyclovoltammetric (CV) characterization, 
surface plasmon resonance expreriment (SPR), and X-ray photoelectron spectroscopy (XPS). 
Immobilizing bio-specific ligands to activate cellular receptors, the potential application as a 
platform for dynamic co-culture was shown.  
The methodologies developed will be collectively applied to develop a model system 
to study adhesion-mediated signaling. The cellular response to geometry and ligand gradients 
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in real time will open new insights of adhesion mediated signaling. Furthermore, the ability 
to control conjugation and cleavage in physiological conditions (pH 7.4, 37.5°C) will be 
valuable to investigate real-time cellular response to adhesion condition changes. For 
example, installing a hydroquinone and oxyamine in both ends of a RGD peptide will enable 
real-time control over the structural constraint of the peptide. Since the cyclic form of RGD 
peptide has ~1000 times stronger cell binding affinity than linear form due to the structural 
similarity to FN1, the cellular response to adhesive changes may be monitored (Figure 6.1). 
The results from the dynamic model surfaces will provide new insights to adhesion mediated 
signaling by depicting connections between adhesion-mediated phenomenon.  
 
Figure 6.1 The RGD peptide flanked by CRRL counterparts immobilized onto the surface 
and presented to cells. Since the cyclic forms of the RGD ligand have significantly higher 
integrin binding affinity than the linear form1, this substrate can modulate the adhesiveness 
of the surface by electrochemical switching. The dynamic surface will enable real time 
monitoring of cellular response to the dynamic change of adhesion.   
 
In chapter 5, the conjugation and release strategy on the conductive surface (chapter 
4) was extended as a strategy to form a  cleavable linker between two biomolecules in 
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aqueous solution. The quinone oxime ether in solution, not on the surface, could be cleaved 
by mild biological reductants such as DTT and GSH. Interestingly, the cleaved quinone 
oxime ether yielded alcohol and aminophenol, which is different from the products of surface 
cleavage. The electrochemical cleavage on the surface produced hydroquinone and alcohol, 
where the difference may be caused by the instant release of ammonia by subsequent 
electrochemical redox cycles for the aminophenol on the surface. The electrochemical 
conversion of aminophenol to hydroquinone has been well described in the literature2,3.  
The clean synthesis without the use of catalyst in aqueous solvent to produce 
aminophenol may have a potential impact on the pharmaceutical industry where 
aminophenol is an important chemical intermediate for acetaminophen. Usually industrial 
scale synthesis of aminophenol includes metal catalyzed reduction of nitrophenol in harsh 
conditions (high temperature and pressure), which produces excessive environmental 
pollution and wastewater. More importantly, small amounts of residual catalyst may remain 
in the product batch. Future research will focus on improving applicability and cost 
efficiency of this reaction at the industrial scale  
The CRRL methodology has the unique ability to switch ‘on’ and ‘off’ with 
physiological que (mild oxidative or reductive environment) for chemoselective conjugation. 
This characteristic is important in designing a smart molecule having both CRRL 
counterparts in same molecule. The smart molecule (bio-molecule or chemical sensor) can 
change structural constraints to respond to an oxidative environment, which may cause 
measurable changes in biological activity or signal of the probes.  
Chemical linker cleavability in a reducing environment has been important in the 
preparation of immunotoxins4. Immunotoxins, first reported 30 years ago, are a chimeric 
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targeting protein (either an antibody or growth factor) for specific cells and toxins5,6. Lambert 
et al. showed that a disulfide linkage between the antibody and toxin molecules resulted in a 
potent toxicity when compared to non-cleavable linkages7. The disulfide bond, a natural 
reductively cleavable linker, has been applied successfully to design effective immunotoxins. 
However, there always have been concerns about the intrinsic lack of chemoselectivity and 
premature cleavage associated with the disulfide bond. For example, when several cysteins 
are exposed at the surface of target proteins, application of this methodology produces 
isomers, which should be avoided in pharmaceutical applications. The easy installation of 
hydroquinone and oxyamine groups, the chemoselective conjugation between them, as well 
as linear cleavage profile in 5mM GSH in PBS (pH 7.4) strongly suggests this methodology 
can be used as a cleavable linker for immunotoxins. Future efforts will directed towards 
obtaining actual cleavage profiles in the cytosol. Membrane permeable FRET pairs 
connected by quinone oxime ether will be introduced to the cell to monitor CRRL cleavage 
in real time. Several targeting moieties (antibodies, growth factors or peptides) for cancer 
cells tethered with FRET donor will be connected to FRET quencher through CRRL linker. 
The endocytosis, dissociation and subsequent fate will be monitored and characterized. 
Cytotoxicity and cellular metabolism of aminophenol, a CRRL byproduct, should also be 
characterized and an optimized strategy to incorporate a hydroquinone or oxyamine in the 
antibody or growth factor also needs to be developed. 
The CRRL strategy is unique and novel class of chemistry that allows bio-orthogonal and 
chemoselective conjugation followed by subsequent cleavage. Furthermore, CRRL 
conjugation and cleavage can be controlled by biologically relevant redox signals. The 
reactions are fast, quantitative and clean (no catalyst) in physiological conditions. Together 
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with our novel biological model system, we believe that this new chemistry will enable us to 
interrogate unprecedented areas of biology as well as adding valuable bio-organic tools for 
scientist in various fields. 
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Figure A1. NMR and MS data for quinone oxime (QO) and aminophenol (AP) separated 
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 by HPLC from reactions of CRRL conjugation and cleavage (Figure 6c and 6d) (a) NMR 
data of QO (b) NMR data of AP (c) MS data of AP 
 
 
Figure A2. UV spectrometry  characterization of QO degradation in the 5 mM glutathion 
(GSH) which is cytoplasm concentration of GSH. (a) UV spectra characterization for the 
cleavage reaction versus time (QO: 320 nm, AP: 297 nm). Spectra are obtained in every 20 
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min. (b) A plot of QO (100 !M) absorbance (320 nm) versus time in the presence of the 
reductant GSH (5 mM). 
 
 
 
 
 
Figure A3. UV spectrometry  characterization of QO stability in the PBS solution. QO 
solution (100 !M, PBS) is stored in a glass bottle for two weeks under dark condition.   The 
negligible change of the UV absorbance at 320 nm suggests that the QO is very stable in 
PBS. 
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Figure A4. UV absorbance spectra of CRRL species. The molecules were dissolved in PBS 
solution (100 !M). BQ (248 nm, 20,310 M-1cm-1); HQ (288 nm, 2,520 M-1cm-1); QO (320 
nm, 18,163 M-1cm-1); AP (297 nm, 2,150 M-1cm-1) 
 
 
 
 
 
 
 
